EurekaMag PDF full texts Chapter 35,826

Satoh, H.; Kubota, N.; Terauchi, Y.; Takamoto, I.; Manome, Y.; Akanuma, Y.; Nagai, R.; Kadowaki, T. 2003: TY-51501, a novel halobenzyltyrosine derivative, ameliorates insulin resistance and up-regulates adiponectin in vivo. Diabetes 52(Suppl 1): A144

Hoshi, A.; Leeson, P.; Castener, J. 1999: TZT-1027 Antineoplastic. Drugs of the Future 24(4): 404-409

Hashiguchi, N.; Kubota, T.; Maeda, S.; Yoshinare, K.; Suganuma, K.; Kuwano, Y.; Yamamoto, K.; Yoshida, M.; Furukawa, T.; Hasegawa, H.; Otari, Y.; Watanabe, M.; Kumai, K.; Kitajima, M. 2002: TZT-1027 inhibits in vitro cultured cell lines and in vivo growth of human cancer cells. Proceedings of the American Association for Cancer Research Annual Meeting 43: 736

Dalmau, J.; Graus, F.; Barnett, M.; Pringsheim, T.; Caminero, A.; Wennberg, R.; Ribalta, T.; Shannon, P.; Sutton, I.; Eichen, J.; Rosenfeld, M.R. 2000: Ta antibodies in women with paraneoplastic neurologic syndromes. Neurology 54(7 Supp 3): A37-A38

MaoXinGuo; ZhangHongYing; TianShanJun; ChangXiaoPing; JingRuiLian 2010: TaSnRK24, an SNF1-type serine/threonine protein kinase of wheat , confers enhanced multistress tolerance in Arabidopsis. Journal Of Experimental Botany: 3, 683-696

Pelchy, T.E.; Grecco, J.E.; Johnson, E.A.; Vivenzio, R.L.; West, D.J.; Bingham, R.L. 1999: Tab imager assembly for use in an endoscope. Official Gazette of the United States Patent and Trademark Office Patents 1218(2): 1050

Matsuomoto, K.; Nishida, E. 1999: Tab1 protein and DNA coding therefor. Official Gazette of the United States Patent and Trademark Office Patents 1228(4)

Krcmar, S.; Mikuska, J.; Chvala, M. 2002: Tabanidae of western and central Balkans Bosnia and Herzegovina, Serbia, Montenegro, Vojvodina, Kosovo and Macedonia. Acta Universitatis Carolinae Biologica 46(4): 305-320

Nose, K.; Hayakawa, K. 1999: Table. Official Gazette of the United States Patent and Trademark Office Patents 1224(4)

Nose, K.; Izuhara, A. 2002: Table and MR apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1258(1)

Feudtner, C. 2000: Table talk Or, the ordering of modern diabetic life through medical monitoring. Pediatric Research 47(4 Part 2): 128A

Oku, S.; Kumakura, Y.; Momose, T.; Ohtake, T.; Ohtomo, K.; Yamaguchi, T. 1999: Table-based conversion of standardized uptake value of PET increased the accuracy of the diagnosis of the lung tumor. Journal of Nuclear Medicine 40(5 Suppl): 291P

Sarmanaev, S.K.; Aidarova, L.F. 2003: Table-based method of prognosis in cases of mineral acids poisonings. Toxicology Letters (Shannon) 144(Suppl 1): s164

Hagge Greenberg, A.; Gannon, P.; Levine, M.; Kheck, N.; Marquez, S. 2004: Table-side digital augmentation of gross anatomy education. FASEB Journal 18(4-5): Abstract 486

Blamey, R.W.; Morgan, D.A.L.; Mitchell, M. 2001: Tables of anticipated benefit from adjuvant therapy for the individual. Breast Cancer Research and Treatment 69(3): 248

Alberty, R.A. 1999: Tables of standard transformed Gibbs energies of formation for biochemical reactants at pH 7. FASEB Journal 13(7): A1523

Miller, M. 2000: Tablespread product containing liquid fat and process for preparing same. Official Gazette of the United States Patent and Trademark Office Patents 1231(2)

Luber, J.R.; Bunick, F.J. 2001: Tablet and process for making the same. Official Gazette of the United States Patent and Trademark Office Patents 1248(2)

Watanabe, Y.; Morimoto, K.; Iwase, Y. 2004: Tablet and process for producing tablets. Official Gazette of the United States Patent and Trademark Office Patents 1284(3)

Kim, J.S. 2002: Tablet cassette installation-error preventing system for automatic tablet supplying and packaging apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1257(2)

Moroni, A.; Nerella, N.G.; Drefko, W. 2003: Tablet coating composition. Official Gazette of the United States Patent and Trademark Office Patents 1274(3)

Yabuki, A.; Kaida, M.; Ando, T.; Ninomiya, N.; Ozaki, M. 2003: Tablet composition. Official Gazette of the United States Patent and Trademark Office Patents 1276(1)

Yabuki, A.; Kaida, M.; Ando, T.; Ninomiya, N.; Ozaki, M. 2001: Tablet composition of N- -D-phenylalanine. Official Gazette of the United States Patent and Trademark Office Patents 1251(1)

Seth, P. 2002: Tablet comprising a delayed release coating. Official Gazette of the United States Patent and Trademark Office Patents 1255(4)

Grimmett, F.W.; Davidson, N.P. Mccreath 2000: Tablet containing a coated core. Official Gazette of the United States Patent and Trademark Office Patents 1239(4)

Trubiano, P.; Boyd, D. 2000: Tablet containing an enzymatically converted starch derivative encapsulating agent. Official Gazette of the United States Patent and Trademark Office Patents 1236(2)

Cho, K.R.; Park, K.S.; Choi, J.H. 2004: Tablet detecting system for molding tablet supplying apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1285(5)

Petzold, W.; Sudkamp, L. 2001: Tablet dispenser. Official Gazette of the United States Patent and Trademark Office Patents 1249(2)

Kanoyadani, T.; Iwamoto, T. 2003: Tablet dispenser. Official Gazette of the United States Patent and Trademark Office Patents 1268(2)

Kim, J.H. 2003: Tablet dispensing and packaging system. Official Gazette of the United States Patent and Trademark Office Patents 1271(4)

Gribbon, E.M.; Martyn, G.P.; Colaco, C.A. Leo Selwyn 2001: Tablet dosage form of clavulanic acid and amoxycillin comprising a trehalose excipient. Official Gazette of the United States Patent and Trademark Office Patents 1243(4)

Hashimoto, H.; Minami, T.; Hamada, H. 2004: Tablet feeder. Official Gazette of the United States Patent and Trademark Office Patents 1282(3)

Yuyama, S.; Kodama, T.; Tamura, T. 2003: Tablet filling device. Official Gazette of the United States Patent and Trademark Office Patents 1271(4)

Saslawski, O.; Orlando, L. 2002: Tablet for instant and prolonged release of one or more active substances. Official Gazette of the United States Patent and Trademark Office Patents 1257(3)

Wilhelmsen, P.C. 2001: Tablet giving rapid release of nicotine for transmucosal administration. Official Gazette of the United States Patent and Trademark Office Patents 1247(3)

Yuyama, S.; Hamada, H. 2001: Tablet inspection apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1252(4)

Fischer, W.; Klokkers, K. 1999: Tablet or capsule having a content of stable ranitidine hydrochloride form 1. Official Gazette of the United States Patent and Trademark Office Patents 1223(2)

Brozell, B.J.; Eilertson, S.A. 2002: Tablet package including a tablet hold-down device. Official Gazette of the United States Patent and Trademark Office Patents 1259(1)

Yuyama, S.; Yuyama, H.; Kodama, T.; Murakami, H. 2003: Tablet packing apparatus. Official Gazette of the United States Patent and Trademark Office Patents 1276(2)

Lawson, L.D.; Wang, Z.J.nathan 2000: Tablet quality A major problem in clinical trials with garlic supplements. Phytomedicine 7(Suppl 2): 119

Berner, B.; Louie Helm, J. 2002: Tablet shapes to enhance gastric retention of swellable controlled-release oral dosage forms. Official Gazette of the United States Patent and Trademark Office Patents 1265(1)

Kim, J.S. 2002: Tablet supplying and packaging apparatus having turntable and tablet cassettes. Official Gazette of the United States Patent and Trademark Office Patents 1262(3)

Maggi, L.; Conte, U.; Grenier, P.; Vergnault, G.; Dufour, A.; Jarreau, F.CedillaOis Xavier; Rauch Desanti, C. 2000: Tablet with controlled release of alfuzosine chlorhydrate. Official Gazette of the United States Patent and Trademark Office Patents 1240(3)

Fujita, K. 2002: Tableted product prepared by vacuum freeze-drying of a plant belonging to genus aloe of family Liliaceae and the method for producing same. Official Gazette of the United States Patent and Trademark Office Patents 1259(1)

Chu, J.S.; Yang, Y.; Fix, J.A. 2002: Tablets and methods for modified release of hydrophilic and other active agents. Official Gazette of the United States Patent and Trademark Office Patents 1260(3)

Rapp, K.M.; Willibald Ettle, I. 2001: Tablets containing a sweetening mixture. Official Gazette of the United States Patent and Trademark Office Patents 1246(1)

Goto, T.; Meno, T. 2000: Tablets containing anion exchange resin. Official Gazette of the United States Patent and Trademark Office Patents 1231(2)

Turner, S.J.; Kazemi, S.K.; Borek, T.M.; White, J.S. 2003: Tablets containing heat sensitive materials and method for forming thereof. Official Gazette of the United States Patent and Trademark Office Patents 1274(5)

Furitsu, H.; Kato, A.; Ohwaki, T.; Yasui, M. 2004: Tablets immediately disintegrating in the oral cavity. Official Gazette of the United States Patent and Trademark Office Patents 1283(1)

He, M.M.; Liu, F.Y.; Fix, J.A.; Link, M.; Kang, M.L.; Bombardelli, E. 2002: Tablets incorporating isoflavone plant extracts and methods of manufacturing them. Official Gazette of the United States Patent and Trademark Office Patents 1260(1)

Pinkus, A.G. 1999: Tablets or biologically acceptable implants for long-term antiinflammatory drug release. Official Gazette of the United States Patent and Trademark Office Patents 1218(1): 304

Mizumoto, T.; Masuda, Y.; Kajiyama, A.; Yanagisawa, M.; Nyshadham, J.R.m 2003: Tablets quickly disintegrating in the oral cavity and process for producing the same. Official Gazette of the United States Patent and Trademark Office Patents 1272(2)

Meignant, C.; Verdier, S. 2003: Tablets to be crunched or sucked, comprising iron as active principle. Official Gazette of the United States Patent and Trademark Office Patents 1273(4)

Maltais,A.; Remondetto,G.E.; Subirade,M. 2010: Tabletted soy protein cold-set hydrogels as carriers of nutraceutical substances. Food Hydrocolloids: 5, 518-524

Freeman, H.J. 2002: Tabulation of hematologic, lymphoproliferative and intestinal malignancies in Crohns disease database. Gastroenterology 122(4 Suppl 1): A-430

Fukuda, M.; Mikoshiba, K. 2001: Tac2-N, an atypical C-type tandem C2 protein localized in the nucleus. Febs Letters 503(2-3): 217-218

Sato, H.; Ogino, Y.; Uno, H.; Ohta, T.; Kiyoki, M.; Komoriya, K. 1999: Tacalcitol inhibits TPA induced cutaneous inflammation in hariless mice. Japanese Journal of Pharmacology 79(Suppl 1): 290P

Tinley, T.L.; Hemscheidt, T.K.; Mooberry, S.L. 2001: Taccalonolide A A new microtubule-stabilizing agent. Proceedings of the American Association for Cancer Research Annual Meeting 42: 368

Egan, L.J.; Myhre, M.G. 2003: Tace-mediated ectodomain-shedding of EGFR ligands promotes intestinal epithelial restitution. Inflammation Research 52(Suppl 2): S 106

Tschorsnig, Hans Peter 2001: Tachinid flies from South Tyrol in the Stilfser-Joch National Park. Gredleriana 1: 171-182

Kara, K.; Ozdemir, Y. 2000: Tachinid flies reared from lepidopterous larvae in Central Anatolia. Zoology in the Middle East 20: 117-120

O'hara, James, E. 1999: Tachinidae parasitoids of bertha armyworm. Canadian Entomologist 131(1): 11-28

Abeysinghe, R.D.; Greene, B.; Willingham, M.C.; Sausville, E.A.; Narayanan, V.L.; Planalp, R.P.; Brechbiel, M.W.; Torti, F.M.; Torti, S.V. 2000: Tachpyridine , a novel iron chelator and a potential anti-cancer agent in the treatment of tumors with mutated p53. Proceedings of the American Association for Cancer Research Annual Meeting 41: 771

Turner, J.; Koumenis, C.; Kute, T.E.; Torti, F.M.; Planalp, R.P.; Brechbiel, M.W.; Torti, S.V. 2003: Tachpyridine, a novel iron chelator, induces G2/M cell-cycle arrest and functions as a radiosensitizer in p53+/+ and p53-/- isogenic cell lines. Proceedings of the American Association for Cancer Research Annual Meeting 44: 617

Bravo Luna, M.; Bravo Luna, M.B.L. 1999: Tachycardia Quantitative vs Mendelian model. European Journal of Human Genetics 7(Suppl 1): 140

Burkard, T.; Dohrmann, U.; Dragu, A.; Fliedner, A.; Minami, K.; Koerfer, R.; Radicke, D.; Holubarsch, C.J.F. 2001: Tachycardia affects the ratio between NCX-mRNA expression and SERCA-mRNA expression in human failing myocardium. European Heart Journal 22(Abstract Suppl): 486

Stromstad, M.; Ebbesen, E.; Nielsen, H.B.; Secher, N.H. 1999: Tachycardia after post-exercise muscle ischemia is not caused by central volume depletion. Medicine and Science in Sports and Exercise 31(5 Suppl): S225

Dailey, R.M.; Nelson, L.D.; Scaglione, J.M. 2003: Tachycardia and rhabdomyolysis after intentional ingestion of N,N-Dipropyltryptamine. Journal of Toxicology. Clinical Toxicology 41(5): 742-743

Ravindran, B.K.; Pavri, B.B.; Greenspon, A.J.; Ho, R.T. 2003: Tachycardia during bradycardia: what is the mechanism?. Journal of Cardiovascular Electrophysiology 14(8): 894-896

Wearden, P.D.; Vona Davis, L.; Taylor, D.A.; Hill, R.C.; Fleming, W.W. 2001: Tachycardia in endotoxemia is abolished by reserpine pretreatment but not propranolol treatment. FASEB Journal 15(5): A1124

Satoh, T.; Zipes, D.P. 2000: Tachycardia superimposed on bradycardia prolongs ventricular refractoriness and facilitates arrhythmia induction. Franz, Michael R Monophasic action potentials: Bridging cell and bedside 157-169

Akar, J.G.; DiMarco, J.P. 2001: Tachycardia with atrioventricular dissociation after surgery for single ventricle. Journal of Cardiovascular Electrophysiology 12(9): 1092-1093

Curcio, A.; Mongiardo, A.; Zinzi, S.; Tagliamonte, G.; Falco, M.; Stillo, A.; Achille, F.; Esposito, G.; Chiariello, M.; Indolfi, C. 2003: Tachycardia-induced MAPK superfamily activation in the left ventricular myocardium. Circulation 108(17): IV10

El Hajjar, M.; Hermida, J.S.; Caron, F.M.; Nassif, D.; Bourges-Petit, E.; Maingourd, Y. 2004: Tachycardia-induced cardiomyopathy in children: a difficult diagnosis but a reversible form of left ventricular dysfunction. Archives de Pediatrie: Organe Officiel de la Societe Francaise de Pediatrie 11(1): 24-28

Chen, Y.J.; Chen, S.A.; Lin, C.I. 1999: Tachycardia-induced changes in electropharmacology of pulmonary vein in dogs subjected to chronic rapid atrial pacing. Circulation 100(18): 1; 200

Schoonderwoerd, B.A.; Van Gelder, I.C.; Schelhaas, E.; Hooft Van Huysduynen, B.; Tieleman, R.G.; Bel, K.; Grandjean, J.G.; Crijns, H.J.G.M. 1999: Tachycardia-induced electrical and structural remodelling Differences between atrial and ventricles. European Heart Journal 20(ABSTR Suppl ): 49

He, J.Q.; Haworth, R.A.; Wolff, M.R.; Kamp, T.J. 1999: Tachycardia-induced heart failure causes a reduction in the number of L-type Ca2+ channels measured by nonlinear charge movement. Circulation 100(18): 1; 191

Shinohara, T.; Nakamura, Y. 2002: Tachycardia-induced left ventricular dysfunction in children. Pediatrics International: Official Journal of the Japan Pediatric Society 44(3): 310-313

Wolpert, C.; Jung, W.; Schimpf, R.; Lewalter, T.; Spehl, S.; Herwig, S.; Tenzer, D.; Schulz, T.; Omran, H.; Luederitz, B. 2000: Tachycardias do not endanger safe arrhythmia detection due to imitation of supraventricular tachyarrhythmias Results from a prospective study with two new dual-chamber detection algorithms. European Heart Journal 21(Abstract Suppl): 198

Corboz, M.R.; Rivelli, M.A.; Rizzo, C.A.; Hey, J.A. 2001: Tachykinin NK-1 receptor agonist-induced relaxation in human pulmonary arteries is not mediated by potassium channels. FASEB Journal 15(5): A854

Brunelleschi, S.; Lavagno, L.; Colangelo, D.; Viano, I. 2001: Tachykinin activation of human monocytes from normal and rheumatoid patients Effects of cyclosporin A. British Journal of Pharmacology 133(Proceedings Suppl): 35P

Valente, M.; Mariani, R.; Visentin, L.; Scheideler, M.A. 2000: Tachykinin activation of primary afferents in the periphery measured by stimulation of micturition reflex. European Journal of Neuroscience 12(Suppl 11): 49

Hill, R.G. 1999: Tachykinin antagonist and an opioid analgesic effective at treating pain or nociception. Official Gazette of the United States Patent and Trademark Office Patents 1220(2): 1563

Horwell, D.C.; Howson, W.; Pritchard, M.C.; Roberts, E.; Rees, D.C. 1999: Tachykinin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1218(1): 421-422

Walpole, C.S.mon John; Prashad, M.; Har, D. 2000: Tachykinin antagonists. Official Gazette of the United States Patent and Trademark Office Patents 1237(4)

Patacchini, R.; Maggi, C.A.; Holzer, P. 2000: Tachykinin autoreceptors in the gut. Trends in Pharmacological Sciences 21(5): 166

Chen, M.J.; Lai, Y.L. 2002: Tachykinin dysfunction attenuates monocrotaline-induced pulmonary hypertension. FASEB Journal 16(4): A74

Moriarty, D.V.; Hyland, J.M.P.; O'donoghue, D.P.; Baird, A.W. 1999: Tachykinin induced ion transport responses in human colonic mucosa in vitro. Gut 44(Suppl 1): A102

Manning, B.P.; Mawe, G.M. 2000: Tachykinin mediation of slow excitatory synaptic potentials in guinea pig sphincter of oddi ganglia. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A405

Joos, G.F.; Pauwels, R.A. 2001: Tachykinin receptor antagonists: potential in airways diseases. Current Opinion in Pharmacology 1(3): 235-241

Liu, H.; Mazarati, A.M.; Baldwin, R.; Wasterlain, C.G. 2003: Tachykinin receptor trafficking in status epilepticus. Neurology 60(5 Suppl 1): A517

Takahashi, R.; Nishimura, J.; Hirano, K.; Kanaide, H. 2001: Tachykinin receptors responsible for the contraction of the rabbit corpus cavernosum. Japanese Journal of Pharmacology 85(Suppl 1): 281P

Montuschi, P.; Preziosi, P.; Ciabattoni, G. 2000: Tachykinin-eicosanoid crosstalk in airway inflammation. Trends in Pharmacological Sciences 21(9): 336-340

Percy, W.H.; Fromm, T.H. 2000: Tachykinin-induced responses of rat colonic muscularis mucosae are governed by regional variations in neurokinin receptor subtypes. Gastroenterology 118(4 Suppl 2 Pt 1): AGA A836

Wong, S.S.; Sun, N.N.; Keith, I.; Kweon, C.B.; Foster, D.E.; Schauer, J.J.; Witten, M.L. 2003: Tachykininergic effects in Fischer 344 rats exposed nose-only to the ambient levels of diesel exhaust. Toxicology 191(1): 32, September 15th

Wong, S.S.; Sun, N.N.; Witten, M.L. 2003: Tachykininergic mechanisms of acute respiratory distress syndrome following fire smoke inhalation. FASEB Journal 17(4-5): Abstract 161

Suzuki, H.; Nakano, A.; Konishi, S. 2000: Tachykininergic modulation of inhibitory GABAergic transmission in the rat amygdala. Japanese Journal of Pharmacology 82(Suppl 1): 74P

Suzuki, H.; Konishi, S. 1999: Tachykininergic regulation of synaptic transmission in the rat amygdala. Society for Neuroscience Abstracts 25(1-2): 956

Holzer, P. 2000: Tachykinins From basic concepts to therapeutic implications. Gaginella, T S , Guglietta, A Drug development: Molecular targets for GI diseases 113-146

Matsumoto, A.; Saito, F.; Song, S.Y.; Suzuki, H.; Konishi, S.; Murakoshi, T. 2004: Tachykinins modulate slow oscillatory bursts in the rat amygdala GABA synapse. Journal of Pharmacological Sciences 94(Suppl 1): 283P

Pasricha, P.J.; Saban, R.; Nguyen, N.B.; Saban, M.R. 1999: Tachykinins receptors and non-cholinergic non-adrenergic neurotransmission in the mouse ileum. Gastroenterology 116(4 Part 2): A1061

Goto, T.; Fukuhara, E.; Kometani, K.; Kobayashi, S. 2002: Tachykinins stimulate bone formation by rat calvarial osteoblasts via the neurokinin-1 receptor. Journal of Bone and Mineral Research 17(Suppl 1): S339

Lachman, L.; Lukasik, N.; Greski Rose, P.A.; Chiu, Y.L.; Jennings, D. 1999: Tachyphylaxis Evidence from phase I study in support of treatment with a PPI. Gastroenterology 116(4 Part 2): A227

Wahid, S.; Marbach, P.; Oroszlan, P.; Stolz, B.; Miller, M.; James, A.; Ball, S. 2000: Tachyphylaxis to somatostatin analogues in a patient with acromegaly The role of antibodies to SST analogues and receptor desensitisation. Journal of Endocrinology 164(Suppl ): P219

Jones, R.A. 2002: Tachys parvulus probably widespread in urban London, but you have to know how and where to look. Entomologist's Record and Journal of Variation 114(4): 170-171

Hind, S.H. 2000: Tachystola acroxantha around Manchester History and current status. Entomologist's Record and Journal of Variation 112(3): 127-128

Slade, A.; Farrar, W. 1999: Tachystola acroxantha in Somerset. Entomologist's Record and Journal of Variation 111(5): 232

Harari, B.; Beyar, M.; Globerman, O. 2003: Tack device with shield. Official Gazette of the United States Patent and Trademark Office Patents 1269(2)

Kangas, L.S.; Mazurek, M.H.; Melancon, K.C.; Romanko, W.R.; Sherman, A.A. 2003: Tackified polydiorganosiloxane polyurea segmented copolymers and a process for making same. Official Gazette of the United States Patent and Trademark Office Patents 1277(3)

Tetteh, K.; Conway, D. 2003: Tackling complex antigenic polymorphism with a minimal polyvalent immunogenic protein. Experimental Parasitology 105(1): 70

Ford, N. 2001: Tackling female genital cutting in Somalia. Lancet 358(9288): 1179

Saloojee, H. 2004: Tackling moderate malnutrition: the next frontier. Journal of Pediatric Gastroenterology and Nutrition 38(2): 143-145

Scally, G. 1999: Tackling teenage pregnancy in the UK. Lancet 353(9171): 2178

Kalume, D.E.; Molina, H.; Pandey, A. 2003: Tackling the phosphoproteome: tools and strategies. Current Opinion in Chemical Biology 7(1): 64-69

Kemp, B.M.; Smith, D.G. 2003: Tackling the vagaries of ancient DNA work. American Journal of Physical Anthropology Suppl (36): 127-128

Wang, C. 2001: Tacky attachment method of covered materials on stents. Official Gazette of the United States Patent and Trademark Office Patents 1250(3)

Tirillo, A. 1999: Taco shell blank. Official Gazette of the United States Patent and Trademark Office Patents 1229(1)

Prince, R.J.; Weston, A.H.; Sine, S.M. 2000: Tacrine block of muscle nicotinic acetylcholine receptors. British Journal of Pharmacology 129(Proceedings Suppl): 130P

Hu, M.K.; Shaw, J. 2001: Tacrine derivatives for treating Alzheimers disease. Official Gazette of the United States Patent and Trademark Office Patents 1243(4)

Matter, C.M.; Kurz, D.J.; Wnendt, S.; Kozai, T.; Jaschko, A.; Joch, H.; Grunenfelder, J.; Zund, G.; Luscher, T.F. 2002: Tacrolimus , but not sirolimus targets human vascular smooth muscle cells , but spares endothelial cells Implications for drug-eluting stents. Circulation 106(19): 2; 356-II 357

Cuvello Neto, Americo L.; De Castro, Isac; Costa, Maristela C.; Ferreira, Alice T.; Burdmann, Emmanuel A.; Yu, Luis 2001: Tacrolimus -induced tubular toxicity Role of intracellular calcium, nitric oxide and hydroperoxides. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 799A

Krupnick, A.; Clarke, J.; Fadness, D.; Singer, G.; Lebwohl, M. 2001: Tacrolimus 01% ointment in the treatment of eyelid dermatitis. Journal of Investigative Dermatology 117(2): 533

Scott, J.S.; Boyle, G.J.; Daubeney, P.E.; Miller, S.A.; Law, Y.; Pigula, F.; Griffith, B.P.; Webber, S.A. 1999: Tacrolimus: a cause of hypertrophic cardiomyopathy in pediatric heart transplant recipients?. Transplantation Proceedings 31(1-2): 82-83

Plosker, G.L.; Foster, R.H. 2000: Tacrolimus: a further update of its pharmacology and therapeutic use in the management of organ transplantation. Drugs 59(2): 323-389

Scott, L.J.; McKeage, K.; Keam, S.J.; Plosker, G.L. 2003: Tacrolimus: a further update of its use in the management of organ transplantation. Drugs 63(12): 1247-1297

Reitamo, S. 2001: Tacrolimus: a new topical immunomodulatory therapy for atopic dermatitis. Journal of Allergy and Clinical Immunology 107(3): 445-448

Koenig, J.M.; Matharoo, N.; Stegner, J.J.; Schowengerdt, K.O. 2003: Tacrolimus In vitro effects on neutrophil production and apoptosis. Journal of Heart and Lung Transplantation 22(1S): S96

Hauk, P.J.; Leung, D.Y.M. 2001: Tacrolimus New treatment approach in superantigen-associated diseases like atopic dermatitis?. Journal of Allergy and Clinical Immunology 107(2 Part 2): 391-392

Trevillian, P.; Hibberd, A.; Millar, E.; Nanra, R.; Carney, S.; Gillies, A. 2001: Tacrolimus abolishes subclinical acute rejection in renal allografts at three months. Immunology and Cell Biology 79(4): A23

Dethloff, T.; Hansen, B.A.; Larsen, F.S. 2004: Tacrolimus ameliorates cerebral vasodilatation and intracranial hypertension in the rat with portacaval anastomosis and hyperammonemia. Liver Transplantation: Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society 10(7): 922-927

Kohnle, M.; Zimmermann, U.; Testa, G.; Philipp, T.; Heemann, U. 2001: Tacrolimus and Daclizumab after renal transplantation; a feasible regimen?. Nephrology Dialysis Transplantation 16(6): A212

Pavletic, S.Z.; Abhynakar, S.; Foran, J.; Lynch, J.C.; Mcguirk, J.; Hardiman, P.; Becker, C.; Bierman, P.; Mcsweeney, P. 2002: Tacrolimus and Mycophenolate Mofetil Are Superior to Cyclosporine and Methotrexate for GVHD Prevention after HLA-Matched Related Donor Hematopoietic Cell Transplantation. Blood 100(11): Abstract No. 5352

Meiser, B.M.; Groetzner, J.; Mueller, M.; Koglin, J.; Stempfle, H.; Vogeser, M.; Reichart, B. 2002: Tacrolimus and Sirolimus A new therapeutic approach for immunosuppression after heart transplantation. Journal of Heart and Lung Transplantation 21(1): 84-85

Baran, D.A.; Galin, I.D.; Segura, L.; Courtney, M.C.; Correa, R.; Lansman, S.L.; Spielvogel, D.; Ashkar, J.; Cheng, J.; Fallon, J.T.; Gass, A.L. 2002: Tacrolimus and cardiac transplantation: a comparison of monotherapy and steroid-dependent patients. Transplantation Proceedings 34(5): 1845-1846

Van Hooff, J.P.; van Duijnhoven, E.M.; Christiaans, M.H. 1999: Tacrolimus and glucose metabolism. Transplantation Proceedings 31(7a): 49s-50s

Bessmertny, O.; Farris, K.; Van, D.V., C.; Harrison, L.; Osunkwo, I.; Wolownik, K.; Garvin, J.; George, D.; Del Toro, G.; Bradley, M.B.; Skerrett, D.; Cairo, M.S. 2003: Tacrolimus and mycophenolate mofetil GVHD prophylaxis in pediatric allogeneic SCT recipients Altered MMF pharmacokinetics associated with acute GVHD. Blood 102(11): 713a

Mcsweeney, P.; Abhyankar, S.; Petersen, F.; Devetten, M.; Arcaroli, J.; Zeng, C.; Baron, A.; Hardiman, P.; Mcguirk, J.; Bearman, S.; Nieto, Y.; Foran, J.; Pulsipher, M.; Pavletic, S. 2003: Tacrolimus and mycophenolate mofetil for GVHD prevention after unrelated donor transplants. Blood 102(11): 717a

Mcsweeney, P.; Abhyankar, S.; Blunk, B.; Baron, A.; Foran, J.; Mcguirk, J.; Hardiman, P.; Picken, S.; Pavletic, S. 2002: Tacrolimus and mycophenolate mofetil for GVHD prevention in adult hematopoietic allograft recipients. Experimental Hematology (Charlottesville) 30(6 Suppl 1): 119

Forsythe, J. 1999: Tacrolimus and mycophenolate mofetil in cadaveric renal transplant recipients. Transplantation Proceedings 31(7A): 69S-71S

Mazuecos, A.; Garcia, T.; Ceballos, M.; Garcia, A.; Rivero, M. 2000: Tacrolimus and mycophenolate mofetil in high-risk kidney patients. Nephrology Dialysis Transplantation 15(9): A253

Miller, J. 1999: Tacrolimus and mycophenolate mofetil in renal transplant recipients One year results of a multicenter, randomized dose ranging trial. Transplantation Proceedings 31(1-2): 276-277

Cairo, M.S.; Harrison, L.A.; Ellis, H.; Wolownik, K.; Del Toro, G.; Bradley, M.B.; Yamashiro, D.J.; Garvin, J.H. 2001: Tacrolimus and mycophenolate mofetil is a safe and potentially effective alternative GVHD prophylaxis regimen in related and unrelated donor allogeneic SCT. Blood 98(11 Part 1): 662a-663a

Baran, D.A.; Ashkar, J.; Galin, I.D.; Sandler, D.; Segura, L.; Courtney, M.C.; Correa, R.; Chan, M.; Lansman, S.L.; Spielvogel, D.; Cheng, J.; Gass, A.L. 2002: Tacrolimus and new onset diabetes mellitus: the effect of steroid weaning. Transplantation Proceedings 34(5): 1711-1712

Berloco, P.; Rossi, M.; Pretagostini, R.; Sociu-Foca Cortesini, N.; Cortesini, R. 2001: Tacrolimus as cornerstone immunosuppressant in kidney transplantation. Transplantation Proceedings 33(1-2): 994-996

Groetzner, J.; Meiser, B.; Schirmer, J.; Kur, F.; Muller, M.; Reisch, F.; Uberfuhr, P.; Land, W.; Reichart, B. 2002: Tacrolimus as primary immunosuppressant in simultaneous heart and kidney transplanted patients leads to excellent clinical outcome. Journal of Heart and Lung Transplantation 21(1): 98

Wasserberg, N.; Salgar, S.; Yang, D.; Santiago, S.; Ruiz, P.; Niv, Y.; Ho, S.; Mor, E.; Tzakis, A. 2003: Tacrolimus does not upregulate mucin gene expression after small bowel transplantation in rats. Transplantation Proceedings 35(2): 670-671

Hesselink, D.A.; Nguyen, H.; Wabbijn, M.; Gregoor, P.J.S.ak; Steyerberg, E.W.; Van Riemsdijk, I.C.; Weimar, W.; Van Gelder, T. 2003: Tacrolimus dose requirement is significantly higher when used in combination with corticosteroids. Clinical Pharmacology and Therapeutics 73(2): P81

Rodeck, B.; Kelly, D.; Jara, P.; Reding, R.; Bernard, O.; Burdelski, M.; Becker, M.; Gridelli, B.; Boillot, O.; Manzanares, J. 2002: Tacrolimus dual therapy versus cyclosporin-microemulsion triple therapy in paediatric liver transplant recipients Results of a 12-month comparative Study. Journal of Hepatology 36(Suppl 1): 31

Duncan, N.; Dhaygude, A.; Cairns, T.; Griffith, M.; Mclean, A.; Palmer, A.; Taube, D. 2003: Tacrolimus effectively induces and maintains remission of nephrotic syndrome secondary to non-proliferative glomerulonephritis with preservation of renal function. Journal of the American Society of Nephrology 14(Abstracts Issue): 524A-525A

Koglin, J.; Muscholl, M.; Petrakopoulou, P.; Groetzner, J.; Weis, M.; Meiser, B.; Von Scheidt, W. 2002: Tacrolimus excels cyclosporine A in prevention of cardiac allograft vasculopathy A prospective IVUS, angiography and Doppler study. Journal of Heart and Lung Transplantation 21(1): 68

Kliem, V.; Radermacher, J.; Hiss, M.; Pethig, M.; Burg, M.; Schlitt, H.J.; Breidenbach, T.; Nashan, B.; Brunkhorst, R. 1999: Tacrolimus for acute rejection after kidney transplantation. Nephrology Dialysis Transplantation 14(9): A272

Zamos, D.T.; Tabin, G. 2002: Tacrolimus for high-risk corneal and limbal grafts. Ophthalmology 109(11): 1953

Sandborn, W.J.; Present, D.H.; Isaacs, K.L.; Wolf, D.C.; Greenberg, E.; Hanauer, S.B.; Feagan, B.G.; Johnson, T.; Joseph, G.; Martin, C.F.; Sandler, R.S. 2002: Tacrolimus for the treatment of perianal and enterocutaneous fistulas in patients with Crohns disease A randomized, double-blind, placebo-controlled trial. Gastroenterology 122(4 Suppl 1): A 81

Fieguth, H.-G.; Krueger, S.; Wiedenmann, D.E.; Otterbach, I.; Wagner, T.O.F. 2002: Tacrolimus for treatment of bronchiolitis obliterans syndrome after unilateral and bilateral lung transplantation. Transplantation Proceedings 34(5): 1884

Koenig, J.M.; Matharoo, N.; Stegner, J.J.; Schowengerdt, K.O. 2003: Tacrolimus has no direct adverse effects in vitro on myelopoiesis, neutrophil survival, or upregulation of CD11b. Pediatric Research 53(4 Part 2): 273A

Yan, H.J.; Hiebert, T.; Xue, M.C.; Jones, K.E.; Del Bigio, M.R.; Peeling, J. 1999: Tacrolimus improves behavioral recovery following intracerebral hemorrhage in rat. Society for Neuroscience Abstracts 25(1-2): 584

Galin, I.D.; Baran, D.A.; Correa, R.; Courtney, M.C.; Chan, M.; Spielvogel, D.; Lansman, S.L.; Fallon, J.T.; Gass, A.L. 2003: Tacrolimus in heart transplantation Monotherapy vs steroid requiring patients. Journal of Heart and Lung Transplantation 22(1S): S150

Bilbao, I.; Pou, L.; Castells, L.; Charco, R.; Murio, E.; Hidalgo, E.; Sanchez Avila, J.F.; Margarit, C. 2000: Tacrolimus in monotheraphy in liver transplantation Comparison with dual regimen of tacrolimus with steroids. Hepatology 32(4 Pt 2): 598A

Bilbao, I.; Pou, L.; Lazaro, J.L.; Castells, L.; Charco, R.; Murio, E.; Hidalgo, E.; Sanchez Avila, J.F.; Margarit, C. 2001: Tacrolimus in monotherapy in liver transplant Comparison with a dual regimen of tacrolimus with steroids. Journal of Hepatology 34(Suppl 1): 61-62

Oddis, C.V.; Sciurba, F.C.; Elmagd, K.A.; Starzl, T.E. 1999: Tacrolimus in refractory polymyositis with interstitial lung disease. Lancet 353(9166): 1762-1763

Shapiro, R. 1999: Tacrolimus in solid organ transplantation: an update. Transplantation Proceedings 31(6): 2203-2205

Peters, H.; Moosmayer, I.; Liefeldt, L.; Zidek, W.; Neumayer, H.H.; Beige, J. 2003: Tacrolimus in the treatment of steroid-refractory or -dependent primary nephrotic syndrome. Journal of the American Society of Nephrology 14(Abstracts Issue): 525A

Butani, L.; Radsliff, E.; Makker, S.P. 2003: Tacrolimus induces remission in children with steroid-resistant nephrotic syndrome. Journal of the American Society of Nephrology 14(Abstracts Issue): 39A

Savikko, J.; Taskinen, E.; von Willebrand, E. 2002: Tacrolimus inhibits platelet-derived growth factor ligand and receptor induction as well as rejection changes in rat renal allografts during long-term follow-up. Transplantation Proceedings 34(5): 1382

Rabkin, J.M.; Rosen, H.R.; Corless, C.L.; Olyaei, A.J. 2002: Tacrolimus is associated with a lower incidence of cardiovascular complications in liver transplant recipients. Transplantation Proceedings 34(5): 1557-1558

Li, L.S.; Chen, Q.; Hu, W.X.; Chen, X.; Chen, H.P.; Liu, Z.H. 2003: Tacrolimus is effective for induction treatment of diffuse proliferative lupus nephritis. Journal of the American Society of Nephrology 14(Abstracts Issue): 38A

Serrano, J.; García González, M.; Gómez, M.; Ortiz de Urbina, J.; López Cillero, P.; San Juan, F.; Parrilla, P.; Herrero, J.I. 2002: Tacrolimus is effective in both dual and triple regimens after liver transplantation. Transplantation Proceedings 34(5): 1529-1530

Molina, M.G. 1999: Tacrolimus is highly effective in both dual and triple regimens after renal transplantation. Nephrology Dialysis Transplantation 14(9): A273

Osborne, J.C.; Heller, M.A.; Forman, L.; Kugelmas, M.; Everson, G.; Bak, T.; Wachs, M.; Kam, I.; Trotter, J.F. 2003: Tacrolimus level/dose ratio is significantly higher in hepatitis C liver transplant recipients Impact on cost. Hepatology 38(4 Suppl 1): 228A

Taylor, P.J.; Morris, R.G. 2003: Tacrolimus measurement by microparticle enzyme immunoassay II. Therapeutic Drug Monitoring 25(3): 259-260

Balbontin, F.G.; Kiberd, B.; Squires, J.; Singh, D.; Fraser, A.; Belitsky, P.; Lawen, J. 2003: Tacrolimus monitoring by simplified sparse sampling under the concentration time curve. Transplantation Proceedings 35(7): 2445-2448

Baran, D.A.; Galin, I.; Segura, L.; Correa, R.; Courtney, M.; Lansman, S.; Gass, A. 2001: Tacrolimus monotherapy 8 Year experience in cardiac transplantation. Journal of the American College of Cardiology 37(2 Suppl A): 167A

Baran, D.A.; Sandler, D.; Galin, I.; Segura, L.; Ashkar, J.; Correa, R.; Courtney, M.; Chan, M.; Spielvogel, D.; Lansman, S.; Gass, A. 2001: Tacrolimus monotherapy Intermediate-term results. Circulation 104(17): 2; 759

Baran, D.A.; Kushwaha, S.; Correa, R.; Courtney, M.; Lansman, S.L.; Gass, A.L. 2000: Tacrolimus monotherapy after cardiac transplantation Seven-year experience. Journal of Heart and Lung Transplantation 19(1): 86

Chariat, M.N.; Chariat, M.; Senninger, N.; Dietl, K.H. 2000: Tacrolimus monotherapy after renal transplantation. Nephrology Dialysis Transplantation 15(9): A252

Baran, D.A.; Galin, I.D.; Correa, R.; Courtney, M.C.; Chan, M.; Spielvogel, D.; Lansman, S.L.; Gass, A.L. 2002: Tacrolimus monotherapy in cardiac transplantation Intermediate-term results. Circulation 106(19): II548

Coupes, B.M.; Short, C.D.; Speake, M.; Johnson, R.W.G.; Roberts, I.S.D.; Campbell, B.A. 2001: Tacrolimus monotherapy in renal transplantation Four year follow-up data. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 884A

Coupes, B.M.; Speake, M.; Johnson, R.W.G.; Roberts, I.S.D.; Campbell, B.; Short, C.D. 2002: Tacrolimus monotherapy in renal transplantation: four-year data. Transplantation Proceedings 34(5): 1612-1613

Stempfle, H.U.; Hien, M.; Wiescher, C.; Meiser, B.; Schrepf, R.; Reichart, B.; Theisen, K. 2001: Tacrolimus nephrotoxicity in heart transplant recipients A four-year follow-up. European Heart Journal 22(Abstract Suppl): 402

Jain, A.B.; Mazariegos, G.; Kashyap, R.S.; Fung, J.J.; Starzl, T.; Reyes, J. 2001: Tacrolimus offers total absence of chronic rejection in pediatric liver transplant recipient Follow up of 7-10 years. Hepatology 34(4 Pt 2): 246A

Allen, B.R. 2002: Tacrolimus ointment: its place in the therapy of atopic dermatitis. Journal of Allergy and Clinical Immunology 109(3): 401-403

Stiehm, E.R.; Roberts, R.L.; Kaplan, M.S.; Corren, J. 2003: Tacrolimus ointment does not alter immune responses of eczematous children. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S131

Schneider, J.A.; Herrick, C.A. 2004: Tacrolimus ointment enhances Th1 and Th2 sensitization through the skin. Journal of Investigative Dermatology 122(3): A52

Choi, C.; Nghiem, P. 2001: Tacrolimus ointment in the treatment of chronic cutaneous graft-versus-host disease A case series of 18 patients. Journal of Investigative Dermatology 117(2): 535

Spergel, J.M.; Prenner, B.M.; Rico, J. 2003: Tacrolimus ointment monotherapy is a safe and effective treatment for mild atopic dermatitis. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S156

Hanifin, J.M.; Leung, D.Y.; Paller, A.; Rico, J. 2003: Tacrolimus ointment monotherapy is safe and effective for the long-term treatment of atopic dermatitis in pediatric patients. Journal of Allergy and Clinical Immunology 111(2 Abstract Suppl): S130

Remitz, A.; Kyllönen, H.; Granlund, H.; Reitamo, S. 2001: Tacrolimus ointment reduces staphylococcal colonization of atopic dermatitis lesions. Journal of Allergy and Clinical Immunology 107(1): 196-197

Groetzner, J.; Meiser, B.M.; Schirmer, J.; Koglin, J.; vScheidt, W.; Klauss, V.; Cremer, P.; Reichenspurner, H.; Reichart, B. 2001: Tacrolimus or cyclosporine for immunosuppression after cardiac transplantation: which treatment reveals more side effects during long-term follow-up?. Transplantation Proceedings 33(1-2): 1461-1464

Hashimoto, T.; Yamada, T.; Ohara, H.; Nakazawa, T.; Sano, H.; Ogasawara, T.; Ando, H.; Hasegawa, C.; Kajino, S.; Ando, T.; Yokoi, T.; Itoh, M. 1999: Tacrolimus prevented apoptosis of pancreatic acinar cells and chronic pancreatitis in WBN/Kob rats. Gastroenterology 116(4 Part 2): A1132

Matsubara, M.; Gu, Z.B.; Kawase, K.; Sawada, A.; Yamamoto, T.; Kitazawa, Y. 2000: Tacrolimus reduces secondary degeneration of the retinal ganglion cell in an ocular hypertensive model and an optic nerve crush model in the rat. IOVS Investigative Ophthalmology and Visual Science 41(4): S829

Manu, M.A.; Tanabe, K.; Ishikawa, N.; Tokumoto, T.; Oshima, T.; Shinmura, H.; Harano, M.; Otsubo, S.; Inui, M.; Kanematsu, A.; Fuchinoue, S.; Toma, H. 1999: Tacrolimus rescue for resistant rejection, chronic rejection, and immunoglobulin a nephropathy of renal allografts under primary cyclosporine a immunosuppression. Transplantation Proceedings 31(7): 2853-2855

Hymes, L.C.; Warshaw, B.L. 2000: Tacrolimus rescue therapy for children with acute renal allograft rejection. Journal of the American Society of Nephrology 11(Program and Abstract Issue): 691A

Filler, G.; Neuschulz, I.; Vollmer, I.; Amendt, P.; Hocher, B. 1999: Tacrolimus reversibly reduces insulin secretion in renal transplantation. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 756A

Yiu, V.; Gowrishankar, M.; Loeffler, K. 2003: Tacrolimus therapy in pediatric patients with treatment resistant forms of nephrotic syndrome. Journal of the American Society of Nephrology 14(Abstracts Issue): 525A

Egidi, M.F.; Cowan, P.A.; Gaber, L.W.; Stratta, R.J.; Shokouh Amiri, H.; Grewal, H.P.; Vera, S.H.; George, C.M.; Honaker, M.R.; Gaber, A.O. 2001: Tacrolimus toxicity in transplantation Management issues and outcomes in patients converted to Sirolimus. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 886A

Ebbs, A.; Pan, F.; Wynn, C.; Erickson, L.; Kobayashi, M.; Jiang, H. 2002: Tacrolimus treats ongoing allograft rejection by inhibiting interleukin-10 mediated functional cytotoxic cell infiltration. Transplantation Proceedings 34(5): 1378-1381

Toda, F.; Tanabe, K.; Ito, S.; Shinmura, H.; Tokumoto, T.; Ishida, H.; Toma, H. 2002: Tacrolimus trough level adjustment after administration of fluconazole to kidney recipients. Transplantation Proceedings 34(5): 1733-1735

Schirmer, J.; Meiser, B.; Kadner, A.; Von Scheidt, W.; Klauss, V.; Cremer, P.; Groetzner, J.; Schenk, S.; Überfuhr, P.; Reichenspurner, H.; Reichart, B. 2001: Tacrolimus versus cyclosporine after HTX: comparison of long-term effects. Journal of Heart and Lung Transplantation: the Official Publication of the International Society for Heart Transplantation 20(2): 191

Pascual, I. 2000: Tacrolimus versus ciclosporin-microemulsion after renal transplantation Results of a large, prospective, randomized trial. Nephrology Dialysis Transplantation 15(9): A252

Ligtenberg, G.; Hene, R.J.; Blankestijn, P.J.; Koomans, H.A. 1999: Tacrolimus versus cyclosporin A A favorable vascular risk profile in renal transplant recipients. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 736A

Egfjord, M.; Ladefoged, J.; Olgaard, K. 2002: Tacrolimus versus cyclosporin in combination with prednisone, mycophenolat mofetil, and ATGAM for primary prevention of acute renal allograft rejection. Nephrology Dialysis Transplantation 17(Abstracts Suppl 1): 177

Mühlbacher, F. 2001: Tacrolimus versus cyclosporin microemulsion in liver transplantation: results of a 3-month study. Transplantation Proceedings 33(1-2): 1339-1340

Land, W.; Malaise, J.; Sandberg, J.; Langrehr, J. 2002: Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation: preliminary results at 1 year of a large multicenter trial. Transplantation Proceedings 34(5): 1911-1912

Nakache, R.; Malaise, J.; Land, W. 2000: Tacrolimus versus cyclosporine in primary simultaneous pancreas-kidney transplantation Preliminary results at 3 months. Acta Diabetologica 37(3): 160-161

Stempfle, H.U.; Hien, M.; Meiser, B.; Frost, R.; Schrepf, R.; Reichart, B.; Theisen, K. 2002: Tacrolimus versus cyclosporine nephrotoxicity in heart transplant recipients A four-year follow-up. Journal of the American College of Cardiology 39(5 Suppl A): 145A

Burroughs, A.; Rolles, K.; Gimson, A.; Jamieson, N.; Hudson, M.; Thick, M.; O'grady, J.; Heaton, N.; Mayer, D.; Neuberger, J.; Macgilchrist, A.; Forsythe, J.; Davies, M.; Pollard, S.; Mccormick, A. 2002: Tacrolimus versus microemulsified cyclosporine in liver transplantation The TMC randomised Trial Final results at one year. Journal of Hepatology 36(Suppl 1): 26

Timmermann, W. 2000: Tacrolimus vs cyclosporin-microemulsion in liver transplantation The German experience. Journal of Hepatology 32(Suppl 2): 49

Zaltzman, J.; McAlister, V.; Russell, D.; Halloran, P.; Landsberg, D.; Busque, S.; Shoker, A.; Boucher, A.; Shapiro, J.; Tchervenkov, J.; Peets, J. 2001: Tacrolimus, MMF, steroid, and ALG immunotherapy for high immunological risk renal transplant recipients. Transplantation Proceedings 33(1-2): 1044-1045

Gonzalez, D.Olano, D. 2004: Tacrolimus, a new treatment to atopic dermatitis An observational pilot study under routine clinical practice conditions. Journal of Allergy and Clinical Immunology 113(2 Suppl): S217

Van Schaik, R.; Hesselink, D.A.; Van Der Heiden, I.P.; Van Der Werf, M.; Lindemans, J.; Van Gelder, T. 2003: Tacrolimus, but not cyclosporine drug levels, are correlated with CYP3A5*3 and CYP3A4*1B genotype No correlation with the MDR-1 C3435T polymorphism. Clinical Pharmacology and Therapeutics 73(2): P56

Allers, C.; Eichhorn, J.; Leckel, K.; Brinkmann, L.; Schmitz-Rixen, T.; Hanisch, E.; Markus, B.H. 2002: Tacrolimus, daclizumab, sirolimus, and budesonide after small bowel transplantation in order to reduce nephrotoxicity. Transplantation Proceedings 34(3): 942

Morales, J.M.; Andrés, A.; Morales, E.; Herrero, J.C.; Cubas, A.; Praga, M.; Hernández, E.; Ortuño, T.; Dominguez-Gil, B.; Carreño, A.; Delgado, M.; Manzanares, C. 1999: Tacrolimus, mycophenolate mofetil and corticosteroids as primary immunosuppression after renal transplantation at the Hospital 12 de Octubre, Madrid. Transplantation Proceedings 31(7a): 75s-77s

Toz, H.; Duman, S.; Sen, S.; Hoscoskun, C.; Ozbek, S.; Basdemir, G.; Basci, A. 2001: Tacrolimus- vs cyclosporin microemulsion-based treatment in renal transplantation Comparison with third month-protocol biopsies. Journal of the American Society of Nephrology 12(Program and Abstract Issue): 950A

Baid, S.; Tolkoff-Rubin, N.; Farrell, M.L.; Delmonico, F.; Williams, W.W.; Hayden, D.; Ko, D.; Cosimi, A.B.; Pascual, M. 2002: Tacrolimus-associated posttransplant diabetes mellitus in renal transplant recipients: role of hepatitis C infection. Transplantation Proceedings 34(5): 1771-1773

Lauzurica, R.; Loscos, J.; Diaz-Couchod, P.; Bayés, B.; de la Camara, J. 2002: Tacrolimus-associated severe bilateral corneal ulcer after renal transplantation. Transplantation 73(6): 1006-1007

Abouljoud, M.S.; Brown, K.A.; Moonka, D.K.; Shick, L.; Douzdjian, V. 2000: Tacrolimus-associated thrombotic thrombocytopenic purpura following liver transplantation. Hepatology 32(4 Pt 2): 345A

Salizzoni, M.; Cavallari, A.; Risaliti, A.; Filipponi, F.; Gerunda, G.E.; Forti, D.; Fassati, L.R.; Cillo, U.; Castagneto, M.; Valente, U.; Tisone, G. 2001: Tacrolimus-based dual therapy is as efficacious and safe as the conventional tacrolimus-based triple therapy in liver transplantation. Transplantation Proceedings 33(3): 2258-2262

Jordan, M.L.; Shapiro, R.; Scantlebury, V.; Vivas, C.; Ellis, D.; Lombardozzi-Lane, S.; Starzl, T.E. 1999: Tacrolimus-based immunosuppression in pediatric renal transplantation. Transplantation Proceedings 31(7a): 29s-30s

Okamoto, M.; Omori, Y.; Kadotani, Y.; Ushigome, H.; Nakamura, K.; Akioka, K.; Yoshimura, N. 2002: Tacrolimus-based immunosuppression in renal transplantation: 78 experiences in a single Japanese center. Transplantation Proceedings 34(5): 1666

Salizzoni, M. 1999: Tacrolimus-based immunosuppression is efficacious and safe with both dual and triple drug regimens following liver transplantation. Hepatology 30(4 Part 2): 171A

Goebel, J.; Jensen, S.; Reddy, K.S.; Jackson, E.C. 2001: Tacrolimus-based immunosuppression with steroid withdrawal in pediatric kidney transplantation Single center experience. Journal of Investigative Medicine 49(1): 132A

Reichenspurner, H.; Kur, F.; Treede, H.; Meiser, B.M.; Welz, A.; Vogelmeier, C.; Schwaiblmeier, M.; Müller, C.; Fürst, H.; Briegel, J.; Reichart, B. 1999: Tacrolimus-based immunosuppressive protocols in lung transplantation. Transplantation Proceedings 31(1-2): 171-172

Ibrahim, R.B.; Abella, E.M.; Chandrasekar, P.H. 2002: Tacrolimus-clarithromycin interaction in a patient receiving bone marrow transplantation. Annals of PharmacoTherapy 36(12): 1971-1972

Shitrit, D.; Starobin, D.; Aravot, D.; Fink, G.; Izbicki, G.; Kramer, M. 2003: Tacrolimus-induced hemolytic uremic syndrome case presentation in a lung transplant recipient. Transplantation Proceedings 35(2): 627-628

Bolley, R.; Zülke, C.; Kammerl, M.; Fischereder, M.; Krämer, B.K. 2002: Tacrolimus-induced nephrotoxicity unmasked by induction of the CYP3A4 system with St John's wort. Transplantation 73(6): 1009

Veroux, P.; Veroux, M.; Puliatti, C.; Morale, W.; Cappello, D.; Valvo, M.; Macarone, M. 2002: Tacrolimus-induced neurotoxicity in kidney transplant recipients. Transplantation Proceedings 34(8): 3188-3190

Outeda Macías, M.; Salvador, P.; Hurtado, J.L.; Martín, I. 2000: Tacrolimus-itraconazole interaction in a kidney transplant patient. Annals of PharmacoTherapy 34(4): 536

Sindhi, R.; Zeevi, A. 2001: Tacrolimus-sparing immunosuppressive effect of sirolimus is associated with increased inhibition of costimulatory targets in transplanted children. Hepatology 34(4 Pt 2): 247A

Meiser, B.; Groetzner, J.; Schirmer, J.; Von Scheidt, W.; Weis, M.; Koglin, J.; Klauss, V.; Stempfle, W.; Cremer, P.; Reichenspurner, H.; Reichart, B. 2001: Tacrolimus/Mycophenolate Mofetil vs Cyclosporine/Mycophenolate Mofetil after HTx Comparison of Mycophenolate Acid trough levels and coronary vasomotor function. Circulation 104(17): 2; 364

Yang, H.C.; Holman, M.J.; Langhoff, E.; Ulsh, P.J.; Dellock, C.A.; Gupta, M.; Ahsan, N. 1999: Tacrolimus/"low-dose" mycophenolate mofetil versus microemulsion cyclosporine/"low-dose" mycophenolate mofetil after kidney transplantation--1-year follow-up of a prospective, randomized clinical trial. Transplantation Proceedings 31(1-2): 1121-1124

Woeste, G.; Wullstein, C.; Dette, K.; Pridöhl, O.; Lübke, P.; Bechstein, W.O. 2002: Tacrolimus/mycophenolate mofetil vs cyclosporine A/Azathioprine after simultaneous pancreas and kidney transplantation: five-year results of a randomized study. Transplantation Proceedings 34(5): 1920-1921

Groetzner, J.; Meiser, B.; Schirmer, J.; Schenk, S.; Muller, M.; Reisch, F.; Oberhoffer, M.; Kur, F.; Ueberfuhr, P.; Reichart, B. 2002: Tacrolimus/mycophenolate mofetil vs cyclosporine/mycophenolate mofetil Impact on infections following cardiac transplantation. Journal of Heart and Lung Transplantation 21(1): 120

Rivera, M.; Luke, P.P.; Shapiro, R.; Vivas, C.A.; Scantlebury, V.P.; Starzl, T.E.; Hakala, T.R.; Jordan, M.L. 2000: Tacrolimus/steroids/Mycophenolate mofetil vs tacrolimus/steroids Long term impact on rejection. Journal of Urology 163(4 Suppl): 311

Neto, A.L.C.vello; Burdmann, E.A.; Castro, I.; Yu, L. 1999: Tacrolymus nephrotoxicity is worsened by jaundice In vivo and in vitro studies. Journal of the American Society of Nephrology 10(Program and Abstr. Issue): 645A

Onar, N. (Gaziyiz); Aktac, N. 2002: Tacsonomic and faunistic studies on the Chrysopidae fauna of Edirne province. Turkiye Entomoloji Dergisi 26(2): 121-134

Lopez Sese, A.; Staub, J.E.; Katzir, N.; Gomez Guillamon, M.L.isa 2001: Tactical assessment of inter- and intra-accession variation in Spanish melon using RAPD and SSR markers. HortScience 36(3): 455

Perez, E.C.; Perez, M.J. 2001: Tactical medical vest and method of providing emergency medical care. Official Gazette of the United States Patent and Trademark Office Patents 1249(4)

Urban, D.L. 2002: Tactical monitoring of landscapes. Liu, Jianguo , Reprint Author, Taylor, William W , Reprint Author Integrating landscape ecology into natural resource management: 294-311

Greenberg, L.; Lohman, C.; Pao, M.; Gracey, D. 1999: Tactile and visual phobic hallucinations An overlooked pediatric syndrome. Pediatric Research 45(4 Part 2): 124A

Nagao, T. 2000: Tactile communication contributes the development of instinctive behavior in male crickets. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 127A(3): 385

Olausson, H.; Morin, C.; Ha, B.; Marchand, S.; Ptito, A.; Bushnell, M.C. 1999: Tactile directional sensibility in hemispherectomized patients. Society for Neuroscience Abstracts 25(1-2): 1683

Pare, M.; Carnahan, H.; Smith, A.M. 1999: Tactile discrimination of tangential force Psychophysical performance in humans. Society for Neuroscience Abstracts 25(1-2): 2196

Abbassian, A.H.; Shahzadi, S.; Afraz, S.R.; Fazl, A.; Moradi, F. 2002: Tactile discrimination task not disturbed by thalamic stimulation. Stereotactic and Functional Neurosurgery 76(1): 19-28

Yanof, J.H.; West, K.J.; Bauer, C.; Kwartowitz, D.M. 2004: Tactile feedback and display in a CT image guided robotic system for interventional procedures. Official Gazette of the United States Patent and Trademark Office Patents 1285(5)

Lander, R.H.; Haberman, S. 1999: Tactile feedback controlled by various medium. Official Gazette of the United States Patent and Trademark Office Patents 1228(3)

Behm, M.D. 2003: Tactile feedback for indicating validity of communication link with an implantable medical device. Official Gazette of the United States Patent and Trademark Office Patents 1276(2)

Reed, C.L.; Shahom, S.; Halgren, E.; Normann, R. 1999: Tactile object recognition activates the secondary somatosensory area An fMRI study. Society for Neuroscience Abstracts 25(1-2): 1894

Okada, J.; Toh, Y. 1999: Tactile orientation behavior in the cockroach Periplaneta americana. Zoological Science 16(Suppl ): 100

Haggard, P.; Taylor-Clarke, M.; Kennett, S. 2003: Tactile perception, cortical representation and the bodily self. Current Biology: Cb 13(5): R170-R173

Bolanowski, S.J.; Pawson, L.; Verrillo, R. 1999: Tactile receptor responses to vibratory stimuli placed on and around their receptive-field centers. Society for Neuroscience Abstracts 25(1-2): 407

Christy, M. 2001: Tactile sensory testing device. Official Gazette of the United States Patent and Trademark Office Patents 1244(1)

Hiraguchi, T.; Takahata, M.; Yamaguchi, T. 1999: Tactile stimulation evoked escape behavior in the cricket, Gryllus bimaculatus. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 124(Suppl ): S132

Guidice, N.A.; Madison, C.M.; Zhuang, J.C.; Costello, P.A.; Legge, G.E.; Hu, X.; He, S. 2000: Tactile vision in the blind An fMRI experiment on pattern recognition and brain plasticity. IOVS Investigative Ophthalmology and Visual Science 41(4): S49

Yeomans, J.S.; Li, L.; Scott, B.W.; Frankland, P.W. 2002: Tactile, acoustic and vestibular systems sum to elicit the startle reflex. Neuroscience and Biobehavioral Reviews 26(1): 1-11

Porst, H. 2003: Tadalafil A viewpoint. Drugs 63(20): 2213-2214

Porst, H.; Rosen, R.C.; Padma Nathan, H.; Varanese, L.; Anglin, G.; Giuliano, F. 2002: Tadalafil allows men with erectile dysfunction to have successful intercourse up to 36 hours postdose. Journal of Urology 167(4 Suppl): 177

Patterson, D.; Macdonald, T.M.; Effron, M.B.; Emmick, J.T.; Mitchell, M.I.; Kloner, R.A. 2002: Tadalafil does not affect time to ischemia during exercise stress testing in patients with coronary artery disease. Circulation 106(19): 2; 330

Hickey, K.; Bokhari, S.; Shahzad, A.; Emmick, J.; Bedding, A.; Stuewe, S.; Beasley, C.; Bergmann, S. 2003: Tadalafil does not alter coronary perfusion at rest or after pharmacological stress in subjects with coronary artery disease. European Heart Journal 24(Abstract Suppl): 563

Hellstrom, W.; Overstreet, J.W.; Yu, A.; Shen, W.; Beasley, C.M.; Watkins, V.S. 2003: Tadalafil has no effect on spermatogenesis or reproductive hormones. Journal of Urology 169(4 Suppl): 245

Padma Nathan, H.; Saikali, K.; Watkins, V.; Yu, A.; Whitaker, S.J. 2002: Tadalafil provides prompt response and extended period of responsiveness for the treatment of men with erectile dysfunction. Journal of Andrology Suppl (Suppl): 58

Padma Nathan, H.; Wei, S.; Yu, A.; Whitaker, S.J. 2002: Tadalafil significantly improves erectile function in men with ED, integrated analysis of registration trials. Journal of Andrology Suppl (Suppl): 58

Pomerol, Jé.María.; Rabasseda, X. 2003: Tadalafil, a further innovation in the treatment of sexual dysfunction. Drugs of Today 39(2): 103-113

Kock, D. 1999: Tadarida latouchei, a separate species recorded from Thailand with remarks on related Asian taxa. Senckenbergiana Biologica 78(1-2): 237-240

Wild, J.; Filutowicz, M. 2003: Tadeusz Klopotowski. Acta Microbiologica Polonica 52(4): 325-328

Spieler, M. 2001: Tadpole aggregation behaviour reduces predation risk. Zoology (Jena) 103(Suppl 3): 52

Lotters, S. 2001: Tadpole of Atelopus mindoensis Peters from Northwestern Ecuador. Copeia 1: 276-278

Mcdiarmid, R.W.; Altig, R. 1999: Tadpoles The biology of anuran larvae. McDiarmid, Roy W , Altig, Ronald Tadpoles: The biology of anuran larvae 7-23

Romano, M.C.; Gomez, Y.; Valdez, R.; Larralde, C. 1999: Taenia crassiceps cysticercus is able to metabolize steroids. Neuroimmunomodulation 6(6): 478

Willms, K.; Zurabian, R. 2010: Taenia crassiceps: in vivo and in vitro models. Parasitology 137(3): 335-346

Wadia, N.H.; Singh, G. 2002: Taenia solium A historical note. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 157-168

Pawlowski, Z.S. 2002: Taenia solium Basic biology and transmission. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 1-13

Willms, K.; Gomez Chavarin, M.; Robert, L. 2000: Taenia solium Chromosomes in dividing cells of adult worms. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 300

Medina Escutia, E.; Lopez Moreno, H.; Tellez Saucedo, D.; Ruiz, A.; Medina Flores, Y.; Vazquez Talavera, J.; Ortiz Navarrete, V.; Laclette, J.P.; Correa, D. 2000: Taenia solium antigen B mapping of B and T cell epitopes. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 298-299

Flisser, A.; Avila, G.; Maravilla, P.; Mendlovic, F.; León-Cabrera, S.; Cruz-Rivera, M.; Garza, A.; Gómez, B.; Aguilar, L.; Terán, N.; Velasco, S.; Benítez, M.; Jimenez-Gonzalez, D.E. 2010: Taenia solium: current understanding of laboratory animal models of taeniosis. Parasitology 137(3): 347-357

Schantz, P.M. 2002: Taenia solium cysticercosis An overview of global distribution and transmission. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 63-73

Wilkins, P.P.; Wilson, M.; Allan, J.C.; Tsang, V.C.W. 2002: Taenia solium cysticercosis Immunodiagnosis of neurocysticercosis and taeniasis. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 329-341

Kumar, A.; Sharma, N. 2002: Taenia solium cysticercosis Ophthalmic aspects. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 269-279

Shandera, W.X.; Schantz, P.M.; White, A.C.inton Jr 2002: Taenia solium cysticercosis The special case of the United States. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 139-143

Singh, G.; Sawhney, I.S. 2002: Taenia solium cysticercosis Uncommon manifestations. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 229-239

Druet Cabanac, M.; Ramanankandrasana, B.; Bisser, S.; Dongmo, L.; Avode, G.; Nzisabira, L.; Dumas, M.; Preux, P.M.rie 2002: Taenia solium cysticercosis in Africa. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 129-137

Tato, P.; Cortes, I.; Solano, S.; Hernandez, L.; Molinari, J.L. 2000: Taenia solium metacestode antigens induce production of Th1 and Th2 cytokines in mice. American Journal of Tropical Medicine and Hygiene 62(3 Suppl): 167

Garcia Noval, J.; Sanchez, A.L.; Allan, J.C. 2002: Taenia solium taeniasis and cysticercosis in Central America. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 91-100

Evans, Carlton, A.W. 2002: Taenia solium vaccination Present status and future prospects. Singh, Gagandeep , Reprint Author, Prabhakar, Sudesh Taenia solium cysticercosis: From basic to clinical science: 421-429

Remadevi, S.; Binoj Kumar, M.S. 2000: Taeniandra micrantha A new record for Kerala. Journal of Economic and Taxonomic Botany 24(2): 320-322

Clarke, A.R.; Zalucki, M.P. 2001: Taeniogonalos raymenti Carmean and Kimsey reared as a hyperparasite of Sturmia convergens , a primary parasite of Danaus plexippus. Pan-Pacific Entomologist 77(2): 68-70

Nesheim, M.E. 1999: Tafi. Fibrinolysis and Proteolysis 13(2): 72-77

Blair, W.; Port, J. 2000: Tag and detection device. Official Gazette of the United States Patent and Trademark Office Patents 1231(4)

Bankston, P. 2004: Tag and release device. Official Gazette of the United States Patent and Trademark Office Patents 1278(3)

Southern, E.; Cummins, W.J.nathan 2001: Tag reagent and assay method. Official Gazette of the United States Patent and Trademark Office Patents 1245(3)

Cover, T.L.; Blaser, M.J.; Kleanthous, H.; Tummuru, M.K.R. 2000: TagA gene and methods for detecting predisposition to peptic ulceration and gastric carcinoma. Official Gazette of the United States Patent and Trademark Office Patents 1240(4)

Kuiack, C.B.; Gleddie, S.C.; Blais, L. 2002: TagTeam The development of a commercial dual inoculant to enhance N-fixation and increase availability of soil phosphate. Finan, Turlough M , Reprint Author, O'Brian, Mark R, Layzell, David B, Vessey, J Kevin, Newton, William Nitrogen fixation: Global perspectives: 495

Coffin, B.; Farmachidi, J.P.; Bastie, A.; Bouhassira, D. 2002: Tagaserod, a 5-HT4 receptor partial agonist, decreases sensitivity to rectal distension in healthy subjects. Gastroenterology 122(4 Suppl 1): A-311

Boelsterli, U.A. 2002: Tagatose as a cytoprotective supplement for the removal and/or storage of organs to reduce reperfusion injury. Official Gazette of the United States Patent and Trademark Office Patents 1256(2)

Smith, L.M.; Hood, L.E.; Hunkapiller, M.W.; Hunkapiller, T.J.; Connell, C.R. 2001: Tagged extendable primers and extension products. Official Gazette of the United States Patent and Trademark Office Patents 1244(2)

Mitsopoulos, G.; Walsh, D.P.; Chang, Y-Tae. 2004: Tagged library approach to chemical genomics and proteomics. Current Opinion in Chemical Biology 8(1): 26-32

Scott, Craig H.; Duffy, Kevin; Ivey, Bert; Batkov, Yevgeniy; Hao, Steven; Axel, Leon; St John Sutton, Martin G.; Ferrari, Victor 2000: Tagged magnetic resonance imaging can quantify regional functional variation during dobutamine stress in subjects with coronary stenoses. Journal of the American College of Cardiology 35(2 Suppl A): 453A

Chang, Young Tae 2003: Tagged small molecule approach to chemical genetics. Abstracts of Papers American Chemical Society 226(1-2): ORGN 328

Hoffman, L.E.; Dell, K.J.; Gubler, W.D. 2002: Tagging flowers to validate an infection risk model for managing strawberry gray mold. Phytopathology 92(6 Suppl): S37

Lim, C.C.; Arora, R.; Krebs, S.L. 2001: Tagging genes for cold hardiness in Rhododendron. HortScience 36(3): 582

Block, B.A.; Costa, D.P.; Boehlert, G.; Kochevar, R. 2002: Tagging of Pacific Pelagics. AAAS Annual Meeting and Science Innovation Exposition 168: A32, 14-19 February

Salgueiro, S.; Steele, S.; Jones, H.D.; Lazzeri, P.A.; Barcelo, P. 1999: Tagging of a MADS-box promoter in a hexaploid cereal. Journal of Experimental Botany 50(Suppl ): 22

Mauersberger, S.; Nicaud, J.M.rc 2003: Tagging of genes by insertional mutagenesis in the yeast Yarrowia lipolytica. Wolf, Klaus , Reprint Author, Breunig, Karin, Barth, Gerold Non-conventional yeasts in genetics, biochemistry and biotechnology: 343-356

Zhang, J.; Jin, Y. 1999: Tagging stem rust resistance gene Sr26 in wheat using RAPD technique. Phytopathology 89(6 Suppl): S89

Nazarko, T.Y.; Nicaud, J.M.; Sibirny, A.A. 2003: Tagging the genes that affect peroxisome degradation in the alkane-utilizing yeast Yarrowia lipolytica. Yeast 20(Suppl 1): S32

Reguer, E.; Ferro, M.; Nugues, E.; Vermat, T.; Cahuzac, R.; Vigouroux, M.; Mouton, E.; Vandenbrouck, Y.; Garin, J.; Viari, A. 2003: Taggor-PepMap, a new software pipeline using LC-MS/MS data for genome annotation. Molecular and Cellular Proteomics 2(7 Suppl): S25

Sanchez Soto, S.; Jimenez Chong, J.A.; Zetina Lanz, M. 1999: Tagosodes orizicolus , a rice pest in the region of Chontalpa, Tabasco state, Mexico. Folia Entomologica Mexicana 106: 125-126

Pouillot, R.; Gerbier, G. 2001: Tags, a program for the evaluation of the diagnostic values of tests in the absence of a gold standard. Menzies, F D Author, Reid, S W Journal Author Society for Veterinary Epidemiology and Preventive Medicine Proceedings 37-48

Tsereteli, D.; Tsiklauril, R.; Tsereteli, N. 1999: Tahyna fever in West Georgia. Journal of Antimicrobial ChemoTherapy 44(Suppl A): 111

Peloquin, D. 2004: Taiga Rescue Network. Scottish Forestry 58(1): 22-24

Helfferich, D. 2002: Taiga ecology Natural labs foster research in the Boreal Forest Zone. Agroborealis 34(1): 20-21

Mcbride, M.; Daly, C.J.; Mcgrath, J.C. 2002: Tail arteries from D79N mice show reduced responses to UK14304 compared with wild type. British Journal of Pharmacology 135(Proceedings Suppl): 304P

Willey, J.S.; Blob, R.W. 2003: Tail function during aquatic walking in snapping turtles. SICB Annual Meeting and Exhibition Final Program and Abstracts : 343

Bragin, A.; Wilson, C.L.; Andres, R.; Mathern, G.; Engel, J.Jr 1999: Tail gamma oscillations as an indicator of enhanced excitability of the brain. Society for Neuroscience Abstracts 25(1-2): 848

Stoneman, D.J. 1999: Tail gate. Official Gazette of the United States Patent and Trademark Office Patents 1226(4)

Van Sluys, M.; Vrcibradic, D.; Rocha, C.F.ederico Duarte 2002: Tail loss in the syntopic lizards Tropidurus itambere and Mabuya frenata in southeastern Brazil. Studies on Neotropical Fauna and Environment 37(3): 227-231

D.G.egorio, A.; Keys, D.; Casey, E.S.; Levine, M.S. 2001: Tail morphogenesis in Ciona intestinalis. Development Growth and Differentiation 43(Suppl): S10

D.G., A.; Silva, C.E.; Harland, R.M.; Levine, M. 2001: Tail morphogenesis in the ascidian, Ciona intestinalis. Development Growth and Differentiation 43(Suppl): S66

Reuter, R.E.; Geddes, M.; Evans, L.H. 2000: Tail rot in southern rock lobsters. Journal of Shellfish Research 19(1): 675

Smith, B.J.; King, J.; Lucas, E.; Stoecker, B.J. 1999: Tail suspension and copper depletion affect bone in mature male rats. FASEB Journal 13(4 Part 1): A578

Park, H.; Park, T. 1999: Tail vs double pigtail ureteral stents Reflux and stent compatibility. Journal of Endourology 13(Suppl 1): A106

Murphy,T.G. 2010: Tail-racket removal increases hematocrit in male Turquoise-browed Motmots. Journal of Ornithology 1(1): 241-245

Cisale, H.; Rivolta, M.; Fernandez, H. 2000: Tail-stump defect in wild boar semen. Biocell 24(3): 264

Cole, A.G.; Meinertzhagen, I.A. 2001: Tailbud embryogenesis and the development of the neurohypophysis in the ascidian Ciona intestinalis. Sawada, H Author, Yokosawa, H Author, Lambert, C C Author The biology of ascidians 137-141

Bruck Gorfung, A.; Ar, A. 2000: Tailed and tailless house geckos do not differ in their specific resting metabolic rate, food consumption, and activity pattern. Israel Journal of Zoology 46(2): 159-160

Jackson, D.J.; Macmillan, D.L. 2000: Tailflick escape behavior in larval and juvenile lobsters and crayfish. Biological Bulletin (Woods Hole) 198(3): 307-318

Gavilan, I.G.; Santos, E.S.; Suarez, S.T.; Alvarez, A. 2003: Tailing leaching technology to remediate mercury contaminated soils. Abstracts of Papers American Chemical Society 225(1-2): ENVR 187

Wolters, J.J.; Reints, D.J.; Matousek, R.A. 2003: Tailings conveyor housing. Official Gazette of the United States Patent and Trademark Office Patents 1277(5)

Johnson, O.W.; Panoushek, D.W.; Walker, E.L.; Svitak, M.J.; Garms, R.C. 2000: Tailings monitor for an agricultural combine. Official Gazette of the United States Patent and Trademark Office Patents 1233(4)

Arafat, A.; Schroën, K.; de Smet, L.C.P.M.; Sudhölter, E.J.R.; Zuilhof, H. 2004: Tailor-made functionalization of silicon nitride surfaces. Journal of the American Chemical Society 126(28): 8600-8601

Dann, E.J.; Haim, N.; Shachar, M.B.; Kirschbaum, M.; Goor, O.; Libster, D.; Israel, O.; Rowe, J.M.; Epelbaum, R. 2002: Tailored BEACOPP Regimen for Unfavorable Hodgkin Lymphoma Based on Early Response to Ga67 /F18dg Scintigraphy and International Prognostic Score for Advanced Disease. Blood 100(11): Abstract No. 3081

Macchia, R.J.; Ruiz Deya, G.; Lang, E.K.; Thomas, R.; Irwin, R., J.; Watson, R.; Richter, F.; Mydlo, J.; Marberger, M. 2001: Tailored CT for assessment of microscopic hematuria. Journal of Urology 165(5 Suppl): 357

Lang, E.K.; Thomas, R. 2003: Tailored CT in diagnosis of bladder lesions causing hematuria. Journal of Urology 169(4 Suppl): 496-497

Castiglione, M. 2003: Tailored adjuvant therapies. EJC Suppls 1(5): S24

Allenspach, L.L.; Chan, K.M.; Klosterman, K.G.; Willcock, L.C.; Bernabei, A.F.; Honasoge, M. 2000: Tailored approach to prevention of bone loss following lung transplantation. Chest 118(4 Suppl): 148S

Blanco, L. 2002: Tailored collection of multicomponent by apheresis. Transfusion and Apheresis Science: Official Journal of the World Apheresis Association: Official Journal of the European Society for Haemapheresis 27(2): 123-127

Kannan, S.; Lieh Lai, M.W.; Kannan, R.M.; Kohle, P.; Glibetic, M. 2002: Tailored dendritic nanostructures for drug delivery. Pediatric Research 51(4 Part 2): 478A

Nagahori, N.; Nishimura, S. 2001: Tailored glycopolymers: controlling the carbohydrate-protein interaction based on template effect. Biomacromolecules 2(1): 22-24

Kolhe, P.; Kannan, S.; Kannan, R.M.; Leih Lai, M.; Gilbatec, M. 2002: Tailored hyperbranched polymers for targeted drug delivery. Abstracts of Papers American Chemical Society 224(1-2): MACR 8

Mohacsi, P.; Schmidli, J.; Hullin, R.; Stalder, M.; Carrel, T. 2002: Tailored immunosuppression: the way we should follow?. Transplantation Proceedings 34(7): 2944-2947

D.Salvo, G.L. 1999: Tailored interferon therapy improves response and cost effectiveness in chronic hepatitis C. Journal of Hepatology 30(Suppl 1): 123

Braun, P.; Seif, C.; Bross, S.; Scheepe, J.R.; Alken, P.; Juenemann, K.P. 2001: Tailored laminectomy Long-term results of bilateral neuromodulation. European Urology 39(Suppl 5): 15

Braun, P.; Seif, C.; Bross, S.; Boschert, J.; Alken, P.; Juenemann, K.P. 2001: Tailored laminectomy for neuromodulator implantation. European Urology 39(Suppl 5): 199

Wunsch, H. 1999: Tailored meningococcal vaccines needed. Lancet (North American Edition) 353(9163): 1502

Ahmad, K. 1999: Tailored prostate cancer vaccine looks promising. Lancet (North American Edition) 354(9189): 1533

Secrest, C.L.; White, P.C. 2000: Tailored scrotal island flap for urethral reconstruction Reliable and durable. Journal of Urology 163(4 Suppl): 71

Zinn, M.; Weilenmann, H.U.; Hany, R.; Schmid, M.; Egli, T. 2003: Tailored synthesis of poly -3-hydroxybutyrate-co-3-hydroxylerate. Acta Biotechnologica 23(2-3): 309-316

Piccart, M.J.; Colozza, M.A.; Sotiriou, C.; Cardoso, F. 2004: Tailored systemic treatment for breast cancer dream or reality?. EJC Suppls 2(3): 2-5

Jukema, J.W.; Kastelein, J.J. 2000: Tailored therapy to fit individual profiles. Genetics and coronary artery disease. Annals of the new York Academy of Sciences 902: 17-24; Discussion: 24-26

Drazner, M.H.; Solomon, M.A.; Thompson, B.; Yancy, C.W. 1999: Tailored therapy using dobutamine and nitroglycerin in advanced heart failure. American Journal of Cardiology 84(8): 941

Francis, P.; Fleming, G.; Nasi, M.L.; Pagani, O.; Perez, E.; Walley, B. 2003: Tailored treatment investigations for premenopausal women with endocrine responsive breast cancer The SOFT, TEXT, and PERCHE Trials. Breast 12(Suppl 1): S44

Gelber, R.D.; Castiglione Gertsch, M.; Coates, A.S.; Goldhirsch, A. 2003: Tailored treatment investigations for premenopausal women with endocrine responsive breast cancer The open questions. Breast 12(Suppl 1): S43-S44

Gelber, R.; Bonetti, M.; Goldhirsch, A. 2002: Tailored treatment investigations using predictive factors. European Journal of Cancer 38(Suppl 3): S125

Milella, Michele; Santantonio, Teresa; Pietromatera, Grazia; De Leo, Maria; Carlone, Raffaella; Tricarico, Domenico; Casalino, Caterina; Genchi, Chiara; Tisci, Angela; Pastore, Giuseppe 2000: Tailored vs standard IFN dosage in chronic hepatitis C. Hepatology 32(4 Pt 2): 464A

Milella, M.; Pietromatera, G.; De Leo, M.; Maselli, R.; Carlone, R.; Tricarico, D.; Casalino, C.; Pastore, G. 1999: Tailored vs standard IFN dosage in chronic hepatitis C End of treatment results. Journal of Hepatology 30(Suppl 1): 232

Epelbaum, R.; Ben Shahar, M.; Avital, D.; Menashe, N.; Rosenbaum, C.; Faraggi, D.; Dahan, G.; Ben Arie, Y.; Kuten, A.; Haim, N. 1999: Tailored-treatment for early stage Hodgkins disease. European Journal of Cancer 35(Suppl 4): S334

Karanfil, T. 2003: Tailoring activated carbons for water and wastewater treatment applications. Abstracts of Papers American Chemical Society 226(1-2): ENVR 81

Johnston, N.; Green, M.; Robb, S.; Morton, I.; Dargie, H. 2003: Tailoring beta-blocker therapy in patients with chronic heart failure utilizing NT-pro-BNP. Journal of the American College of Cardiology 41(6 Suppl A): 144A

Park, D.J.; Stoehlmacher, J.; Lenz, H-Josef. 2003: Tailoring chemotherapy in advanced colorectal cancer. Current Opinion in Pharmacology 3(4): 378-385

Dann, E.J.; Haim, N.; Ben Shachar, M.; Kirschbaum, M.; Goor, O.; Libster, D.; Gaitini, D.; Shalom, R.B.; Rowe, J.M. 2003: Tailoring chemotherapy regimen for standard and high risk Hodgkin lymphoma based on early response to Ga67/F18 DG scintigraphy and international prognostic score for advanced disease A report of 76 patients treated in single institution. Blood 102(11): 638a

Whitt, M.C.; Kumanyika, S.K. 2002: Tailoring counseling on physical activity and inactivity for African-American women. Ethnicity and Disease 12(4): S3

Walsh, C.T.; Chen, H.; Keating, T.A.; Hubbard, B.K.; Losey, H.C.; Luo, L.; Marshall, C.G.; Miller, D.A.; Patel, H.M. 2001: Tailoring enzymes that modify nonribosomal peptides during and after chain elongation on NRPS assembly lines. Current Opinion in Chemical Biology 5(5): 525-534

First, M.R. 2001: Tailoring immunosuppressive therapy based on donor and recipient risk factors. Transplantation Proceedings 33(3): 2207-2211

Vathsala, A. 2002: Tailoring immunosuppressive therapy in renal transplantation. Transplantation Proceedings 34(6): 2478-2479

Hollinger, B.F.; Reddy, R.K.; Layden, T.; Pockros, P.; Lee, W.; Reindollar, R.W.; Tong, M.J.; Carithers, R.; Wright, T.; Gorjon, J.; Poulakos, J.; Willems, B. 1999: Tailoring interferon alfacon-1 treatment of chronic HCV by baseline parameters. Hepatology 30(4 Part 2): 200A

Hogben, M.; Middlestadt, S.E.; Malotte, C.K.; Vandevanter, N.; Messeri, P.; St Lawrence, J.; Ledsky, R.; Bleakley, A.; Settlage, R. 2001: Tailoring interventions to the local context Lessons learned from the gonorrhea community action project. International Journal of STD and AIDS 12(Suppl 2): 204

Beitz, J.V.; Fan, L.; Thiyagarajan, P. 2002: Tailoring nanophases for actinide science and nuclear waste disposal. Abstracts of Papers American Chemical Society 223(1-2): NUCL 138

Cedrone, F.; Ménez, A.; Quéméneur, E. 2000: Tailoring new enzyme functions by rational redesign. Current Opinion in Structural Biology 10(4): 405-410

Mccarthy, C.; Stacey, S.; Man, S. 2000: Tailoring of HPV vaccines based on CTL reactivity against multiple HPV types. Immunology 101(Suppl 1): 26

Ekberg, H. 2003: Tailoring of minimal immunosuppression long term. Transplantation Proceedings 35(2): 755-757

Bielawski, C.W.; Grubbs, R.H. 2003: Tailoring polymer synthesis with designer Ru catalysts. Abstracts of Papers American Chemical Society 226(1-2): POLY 208

Protozanova, E.; Demidov, V.V.; Frank Kamenetskii, M.D. 2003: Tailoring the activity of DNA-processing proteins via sequence-directed DNA looping. Journal of Biomolecular Structure and Dynamics 20(6): 931-932

Roberts, G.C.K.; Cullis, P.M.; Abbott, A.P.; Ahmed, F.; Shaw, A.; Avery, K. 2000: Tailoring the specificity of a self-contained monooxygenase catalyst. Abstracts of Papers American Chemical Society 219(1-2): BIOT 29

Burnett, A.K. 1999: Tailoring the treatment of acute myeloid leukemia. Current Opinion in Oncology 11(1): 14-19

Halloran, P.F.; Melk, A. 2001: Tailoring therapy: balancing toxicity and chronic allograft dysfunction. Transplantation Proceedings 33(3a Suppl): 7s

Vaz, C.M.; Bouten, C.V.C.; Meijer, H.E.H.; Baaijens, F.P.T. 2003: Tailoring tissue engineering poly scaffolds using an electrospinning processing technique. Tissue Engineering 9(4): 820-821

Gelber, R.D.; Bonetti, M.; Goldhirsch, A. 2003: Tailoring treatments for the individual patient. Breast 12(Suppl 1): S15

Zhang, B.; Ganetzky, B.; Bellen, H.J.; Murthy, V.N. 1999: Tailoring uniform coats for synaptic vesicles during endocytosis. Neuron 23(3): 419-422

Ellenberger, T. 2003: Tails of the replication fork unraveling DNA replication in three dimensions. FASEB Journal 17(4-5): Abstract 116

Campellone, K.G.; Leong, J.M. 2003: Tails of two Tirs: actin pedestal formation by enteropathogenic E. coli and enterohemorrhagic E. coli O157:H7. Current Opinion in Microbiology 6(1): 82-90

Lin, M.; Chu, C.C.; Lee, H.L.; Chang, S.L. 2002: Taiwan HLA A-B serology typing tray. Tissue Antigens 59(2 Suppl): 144

Taiwan Offshore Aquaculture Association 2000: Taiwan Offshore Aquaculture Association Reasons to organize and future perspectives. Liao, I Chiu , Reprint Author, Lin, C Kwei Cage aquaculture in Asia: 296

Hwu, H.G.; Tsuang, M.T.; Liu, C.M.; Faraone, S.; Tsuang, M.M.; Chen, W.J.; Liu, S.K.; Sheih, M.H.; Hwang, T.C.; Tsls Study Group 2003: Taiwan Schizophrenia Linkage Study Field Study. American Journal of Medical Genetics 122B(1): 84-85

Chen, K.-C.; Liu, W.-H.; Chang, L.-S. 2010: Taiwan cobra phospholipase A2-elicited JNK activation is responsible for autocrine fas-mediated cell death and modulating Bcl-2 and Bax protein expression in human leukemia K562 cells. Journal of Cellular Biochemistry 109(1): 245-254

Hsu, H.C.; Lee, Y.M.; Su, W.J.; Yang, C.F.; Ho, C.H.; Wang, S.Y.; Liu, W.T. 2001: Taiwanese patients with aplastic anemia do not harbor parvovirus B19 and mycobacterium tuberculosis. Experimental Hematology 29(8 Suppl 1): 32

Choe, Y.H.; Kim, D.K.; Koh, E.M.; Do, Y.S.; Lee, W.R. 1999: Takayasu arteritis Evaluation with contrast-enhanced high-resolution MR imaging. Circulation 100(18): I521-I522

Sugraliev, A.; Arabidze, G.; Nassonov, Y.; Domba, G. 1999: Takayasus Arteritis as risk factor for early development of vascular atherosclerosis. European Heart Journal 20(ABSTR Suppl ): 197

Merkel, P.A.; Kissin, E.Y.; Fredericks, S.E.; Ghani, M.; Tello, R.; Soto, J.A. 2003: Takayasus arteritis Usefulness of contrast-enhanced MRI/MRA in detecting clinically unsuspected lesions. Kidney and Blood Pressure Research 26(4): 290

Hoffman, G.S.; Tso, E.; White, R.D.; Flamm, S.D. 1999: Takayasus arteritis Utility of magnetic resonance imaging in diagnosis and treatment. Arthritis and Rheumatism 42(9 Suppl): S176

Shingadia, D.; Das, L.; Klein-Gitelman, M.; Chadwick, E. 1999: Takayasu's arteritis in a human immunodeficiency virus-infected adolescent. Clinical Infectious Diseases: An Official Publication of the Infectious Diseases Society of America 29(2): 458-459

Uthman, I.W.; Bizri, A.R.; Hajj Ali, R.A.; Nasr, F.W.; Khalil, I.M. 1999: Takayasu's arteritis presenting as fever of unknown origin: report of two cases and literature review. Seminars in Arthritis and Rheumatism 28(4): 280-285

Tran, H.V. 2003: Takayasus arteritis presenting with renal atrophy and nonpulselessness. American Journal of Hypertension 16(5 Part 2): 259A

Unal, N.; Paytoncu, S.; Saylam, G.ül.S.ği.; Kumtepe, S.; Kösecik, M.; Kir, M.; Akçoral, A.; Kozan, O. 2004: Takayasu's arteritis with bilateral renal artery stenosis: unilateral kissing balloon angioplasty. International Journal of Cardiology 93(2-3): 299-300

Ercan, E.; Tengiz, I.; Yakut, N.; Gurbuz, A.; Bozdemir, H.; Bozdemir, G. 2003: Takayasu's arteritis with multiple fistulas from three coronary arteries to lung paranchima. International Journal of Cardiology 88(2-3): 319-320

Serebruany, V.L.; Lowry, D.R. 2000: Take an aspirin or have a drink: antecedent aspirin and moderate alcohol consumption similarly affect baseline platelet characteristics in patients with acute myocardial infarction. Thrombosis and Haemostasis 84(5): 933-934

Kokko, H. 2000: Take care when studying parenting behaviour. Trends in Ecology and Evolution 15(11): 440-441

Win, T.Z.; Mulvihill, D.P.; Hyams, J.S. 2002: Take five: a myosin class act in fission yeast. Cell Motility and the Cytoskeleton 51(2): 53-56

Capone, A.; Trese, M.T. 2002: Take good care of my baby: evolving standards of care for retinopathy of prematurity. Ophthalmology 109(5): 831-833

Meyerhoff,J.; Dehnhardt,A.; Hartje,V. 2010: Take your swimsuit along the value of improving urban bathing sites in the metropolitan area of Berlin. Journal Of Environmental Planning And Management: 1, 107-124

Weisberg, R.A.; Storz, G. 2002: Take your vitamins with a pinch of RNA. Molecular Cell 10(6): 1266-1268

Tobalske, B.W.; Altshuler, D.L.; Powers, D.R. 2001: Take-off mechanics in hummingbirds. American Zoologist 41(6): 1608

Donovan, N.J.; Backhouse, D.; Burgess, L.W. 1999: Takeall suppressiveness as a measure of the effects of management on the microbial buffer in soil. Phytopathology 89(6 Suppl): S21

Lazzari, S.M. Noemberg; Zonta, D.C., R.C.; Cardoso, J.T. 1999: Takecallis arundinariae First record in Brazil and comparison to Takecallis taiwanus. Revista Brasileira de Zoologia 16(3): 865-870

Ganguli Lachungpa, Usha 2000: Takin Budorcas taxicolor at Menla Reserve Forest , east Sikkim A westward range extension and observations of unusual behaviour. Journal of the Bombay Natural History Society 97(2): 272-274

Ackerson, J.D.; Snead, K.E.; Bailey, K.J.; Schmitt, M.M.; Martin, R.C. 2002: Taking Charge of Epilepsy The development of a structured group intervention for adolescents with epilepsy and their parents. Epilepsia 43(Suppl 7): 225

Foster, M.H. 2004: Taking HAART in HIVAN: will protease inhibitor sparing regimens alter renal outcome?. Kidney International 65(3): 1105-1106

Donnez, J.; Jadoul, P. 2004: Taking a history in the evaluation of infertility: obsolete or venerable tradition?. Fertility and Sterility 81(1): 16-17; Discussion 18

Hubacher, David; Grimes, David; Lara Ricalde, Roger; De La Jara, Julio 2004: Taking a history in the evaluation of women with tubal factor infertility. Fertility and Sterility 81(1): 18

Cosmatos, I.; Sternhagen, A. 2000: Taking a product over the counter Ways to look at product safety in actual use. Pharmacoepidemiology and Drug Safety 9(Suppl 1): S137

Carp, R.I.; Kascsak, R.J. 2003: Taking aim at the diagnosis of TSE infectious agents. Abstracts of Papers American Chemical Society 226(1-2): ANYL 9

Yi, B.A.; Jan, L.Y. 2000: Taking apart the gating of voltage-gated K+ channels. Neuron 27(3): 423-425

Wiebusch, L.; Hagemeier, C. 2003: Taking away the replication license HCMV and its impact on cellular DNA synthesis. Proesch, Susanna , Reprint Author, Cinatl, Jindrich, Scholz, Martin New aspects of CMV-related immunopathology: 105-112

Vesta, K.S.; Farmer, K.C.; Kilzer, W.J. 2003: Taking call as pharmacy students A survey of pharmacists opinions of the experience. Pharmacotherapy 23(10): 1336

Dickens, C.; Innes, D.; Parsons, M.; Dawson, A. 2001: Taking cancer information to the community. European Journal of Cancer 37(Suppl 6): S356

Alvarez, A.; Gavilan, I.G.; Santos, E.S. 2003: Taking care of the environment while teaching chemistry. Abstracts of Papers American Chemical Society 225(1-2): CHED 120

Nkwenti, N.D.A. 2003: Taking diabetes education to the grassroots; the case of northwest province of Cameroon. Diabetologia 46(Suppl 2): A93-A94

Evert, A. 2003: Taking diabetes to school A survey of school nurse knowledge of general diabetes management and insulin pump therapy Implications for diabetes educators. Diabetologia 46(Suppl 2): A 419

Blevins, L. 2003: Taking extra precautions in laboratory design Increasing threats of bioterrorism call for greater security measures. American Laboratory 35(25): 10-11

Palmer, D.H..; Chen, M-Jen.; Kerr, D.J.. 2003: Taking Gene Therapy into the Clinic. Journal of Biomedicine and Biotechnology 2003(1): 71-77

Kraus, W.E. 2000: Taking heart failure to new heights: its pathophysiology at simulated altitude. American Journal of Medicine 109(6): 504-505

Porebski, L.M.; Zajdlik, B.A.; Doe, K.G.; Osborne, J.M. 1999: Taking it to the creek Using an organic pollution gradient to evaluate techniques for dredged sediment assessment. Canadian Technical Report of Fisheries and Aquatic Sciences 2293: 49

Jassal, S.V.; Redelmeier, D.A. 2002: Taking organs from the young to give to the old: is this acceptable?. Transplantation 74(3): 416

Aabenhus, R.; Siemer, B.L.; Andersen, L.P.; Permin, H.; On, S.L.W. 2003: Taking out the trash AFLP profiling of Campylobacter concisus and correlation with clinical data identifies a new and emerging human pathogen. IJMM International Journal of Medical Microbiology 293(Suppl 35): 88

Ferl, R.; Paul, A.L. 2001: Taking plants into space Answering fundamental molecular questions of plant stress responses in extraterrestrial environments. AAAS Annual Meeting and Science Innovation Exposition 167: A30, February 15-20

Kellett, M.A. 2003: Taking reaction searches beyond substructure queries Integration with enhanced data sources. Abstracts of Papers American Chemical Society 226(1-2): CINF 100

Windhager, S. 2002: Taking restoration to the masses. Ecological Society of America Annual Meeting Abstracts 87: 55

Pletneva, E.V.; Fulton, D.B.; Winkler, J.R.; Gray, H.B. 2003: Taking snapshots of cobalt cytochrome c folding Real-time NMR studies. Journal of Inorganic Biochemistry 96(1): 211, 15 July

Sabelis, M.W.; Metz, J.A.J. 2002: Taking stock Relating theory to experiment. Dieckmann, Ulf , Metz, Johan A J , Sabelis, Maurice W , Sigmund, Karl Cambridge Studies in Adaptive Dynamics Adaptive dynamics of infectious diseases: In pursuit of virulence management 379-398

Sturm, M.; Cheuvront, A. 2002: Taking teachers out in the wild Winter science in the TEA NSF program. Arctic Science Conference Abstracts 53: 220

Mani, K.; Ashton, A.W.; Kitsis, R.N. 2002: Taking the BAD out of adrenergic stimulation. Journal of Molecular and Cellular Cardiology 34(7): 709-712

Senior, K. 1999: Taking the bite out of snake venoms. Lancet 353(9168): 1946

Collins, J.S.; Nave, A.F.; Satten, G.A.; Stevenson, R.E. 2001: Taking the challenge Finding recurrence risks in idiopathic mental retardation. American Journal of Human Genetics 69(4 Suppl): 224

Reinecke, H.; Murry, C.E. 2002: Taking the death toll after cardiomyocyte grafting: a reminder of the importance of quantitative biology. Journal of Molecular and Cellular Cardiology 34(3): 251-253

Chiller, T.M.; Mendoza, C.E.; Lopez, M.B.; Alvarez, M.; Hoekstra, R.M.; Keswick, B.H.; Luby, S. 2003: Taking the dirt out of dirty water Introducing a new flocculent-disinfectant for household treatment of drinking water dramatically reduces diarrhea in rural Guatemala. American Journal of Tropical Medicine and Hygiene 69(3 Suppl): 427

Stathopulos, P.B. 2003: Taking the good out of the bad: lentiviral-based gene therapy of the hemoglobinopathies. Biotechnology Advances 21(6): 513-526

Green, F.R. 2001: Taking the hype out of hyperfibrinogenaemia?. Thrombosis and Haemostasis 86(2): 509-510

Margaret, C. 2004: Taking the iniative. Australian Veterinary Journal 82(5): 262

Warrell, D.A. 2003: Taking the sting out of ant stings: venom immunotherapy to prevent anaphylaxis. Lancet 361(9362): 979-980

Fain, G.B.; Eakes, J.; Williams, D.; Sibley, J. 2002: Taking theory to the field in landscape construction. HortScience 37(5): 740

Ziegler, T.; Bischoff, W. 1999: Takydromus kuehnei vietnamensis ssp n, a new subspecies of grass lizard from Vietnam. Salamandra 35(4): 209-226, 31 Dezember

Wen, J.; Kohwi Shigematsu, T.; Noguchi, C.T. 2002: Tal1 Exhibits Transcriptional Repression and Modifies RARbeta Gene Expression by Targeting Satellite DNA. Blood 100(11): Abstract No. 2848

Wen, J.; Noguchi, T.; Shigematsu, K. 2001: Tal1 binding to centromeric satellite DNA A new role for Tal1 in transcription repression. American Journal of Human Genetics 69(4 Suppl): 367

Wen, J.; Dickinson, L.A.; Pack, S.D.; Yu, X.; Kohwi Shigematsu, T.; Noguchi, C.T. 2003: Tal1/SCL represses transcription of target DNA via histone methylation. Blood 102(11): 345a

Andrasi, F. 2001: Talampanel Antiepileptic, neuroprotectant, skeletal muscle relaxant. Drugs of the Future 26(8): 754-756

Manes, N.; Rodriguez Panadero, F.; Bravo, J.L.; Hernandez, H.; Alix, A. 2000: Talc pleurodesis Prospective and randomized study Clinical follow-up. Chest 118(4 Suppl): 131S

Garcia, J.P.; Cruz, A.O.; Labrador, M.M.; Toledano, R.G. 2000: Talc slurry as pleurodesing agent in pneumothorax. Chest 118(4 Suppl): 258S

Tarnawski, A.S.; Wang, H.; Tomikawa, M.; Pai, R.; Sarfeh, I.J. 1999: Talcid triggers induction of heat shock proteins HSP-70 in gastric mucosa A key to its mucosal protective action?. Gastroenterology 116(4 Part 2): A331

Chehab, M.N.; Puri, P.M.; Sona, P. 2000: Talcum powder composition. Official Gazette of the United States Patent and Trademark Office Patents 1239(3)

Mcfall Ngai, Margaret 1999: Tales from the crypt The squid-vibrio model sheds light on the mechanisms of symbiosis. Comparative Biochemistry and Physiology Part A Molecular and Integrative Physiology 124(Suppl ): S1

Jin, K.; Greenberg, D.A. 2003: Tales of transdifferentiation. Experimental Neurology 183(2): 255-257

Brody, T.; Stivers, C.; Odenwald, W.F. 2000: Talin A conserved cytoskeletal linker protein expressed in a subset of CNS neurons. Developmental Biology 222(1): 254

Nayal, A.; Webb, D.J.; Horwitz, A.F. 2004: Talin: an emerging focal point of adhesion dynamics. Current Opinion in Cell Biology 16(1): 94-98

Tadokoro, Seiji; Shattil, Sanford J.; Eto, Koji; Tai, Vera; Liddington, Robert C.; De Pereda, Jose M.; Ginsberg, Mark H.; Calderwood, David A. 2003: Talin binding to integrin beta cytoplasmic tails is a final common pathway for cellular activation of integrins. Blood 102(11): 161a

Brzóska, E.; Wróbel, E.; Moraczewski, J. 2001: Talin Distribution During Differentiation Of Satellite Cells Isolated From M. EDL And M. Soleus Treated By Phorbol Ester. Cellular and Molecular Biology Letters 6(2): 191

Bernsdorf, A.; May, K.; Moeritz, K.U.; Zschiesche, M.; Kunert Keil, C.; Kroemer, H.K.; Siegmund, W. 2001: Talinolol is better absorbed and wider distributed in rats with defective MRP2 expression. Naunyn-Schmiedeberg's Archives of Pharmacology 363(4): R120

Schwarz, U.I.; Dresser, G.K.; Oertel, R.; Kim, R.B. 2001: Talinolol-verapamil interaction is not solely due to P-glycoprotein inhibition. Clinical Pharmacology and Therapeutics 69(2): P85

Morvan, D.; Madelmont, J.C.; Demidem, A. 2003: Talk between primary CENU-treated tumors and secondary untreated melanoma tumors through tumor tissue phosphoethanolamine levels. Proceedings of the American Association for Cancer Research Annual Meeting 44: 915-916

Hess, U.; Bourgeois, P.; Murard, N.; Cheung, N. 2000: Talk to me facial emotional expressivity as a function of sex and status in dyadic interactions. Psychophysiology 37(Suppl 1): S47

Millhauser, G.L.; Anderson, D.J.; Mcnulty, J.; Toniolo, C.; Crisma, M.; Formaggio, F. 2000: Talking about TOAC A novel electron spin resonance probe of peptide conformation. Fields, Gregg B , Tam, James P , Barany, George Peptides for the new millennium 267-269

Fallowfield, L. 2002: Talking about difficult things in cancer Do we achieve what patients need?. Drugs of Today 38(Suppl A): 79-87

Lucassen, A.; Parker, M. 2000: Talking about false paternity in the genetic clinic Some ethical considerations. Journal of Medical Genetics 37(Suppl 1): S19

Niemczyk, S.; Kulicki, P.; Dzieciol Jastrzebska, M.; Sitkowska Kurzec, Z.; Gomolka, M.; Skorupinska, A. 2000: Talking about sex Viagra Safety and efficacy in dialysed patients. Nephrology Dialysis Transplantation 15(9): A26

Schnaper, H.W.; Poncelet, A.C.; Hayashida, T. 2001: Talking at cross purposes: molecular interactions downstream from TGF-beta. Kidney International 60(6): 2415-2416

Shadley, J.R.; Hill, P.S.M. 2000: Talking back Sending soil vibration signals to lekking prairie mole cricket males. American Zoologist 40(6): 1207

Leal, S.M.; Neckameyer, W.S. 2002: Talking the talk: the role of VEGF proteins in cell signaling. Trends in Endocrinology and Metabolism: Tem 13(8): 319-320

Dulcan, M.K. 2003: Talking to families about ADHD Editors comment. Journal of the American Academy of Child and Adolescent Psychiatry 42(12): 1386-1387

Doall, M.; Carlson, A.D. 2003: Talking to fireflies Recruiting the next generation of firefly biologists. SICB Annual Meeting and Exhibition Final Program and Abstracts : 157

Roth, H.; Kahler, A.; Brodsky, N.L.; Hurt, H. 1999: Talking to postpartum moms Are we competing with the television?. Pediatric Research 45(4 Part 2): 131A

Ben-Ami, H.; Behar, D.M.; Fischer, D.; Edoute, Y. 2000: Talking to the patient. Lancet 356(9235): 1076

Salisbury, L.; Children Now; Zimmerman, V.; New York University Medical School; Mchugh, P. 1999: Talking with kids about tough issues. Pediatrics 104(3 Part 3): 699

Perlman, A.I.; Eisenberg, D.M.; Panush, R.S. 1999: Talking with patients about alternative and complementary medicine. Rheumatic Diseases Clinics of North America 25(4): 815-822

Ensinger, C.; Prommegger, R.; Kremser, R.; Schmid, K. 2003: Tall cell variant is frequent in all types of papillary thyroid carcinomas in 405 investigated cases. Virchows Archiv 443(3): 292

Waller, J.C.; Schrick, F.N.; Dixon, M.C.; Fisher, A.E.; Saxton, A.M.; Fribourg, H.A. 2001: Tall fescue based forage systems for developing beef replacement heifers. Journal of Dairy Science 84(Suppl 1): 458

Latch, G.C. Morland; Christensen, M.J.; Tapper, B.A.; Easton, H.S.; Hume, D.E.; Fletcher, L.R. 2000: Tall fescue endophytes. Official Gazette of the United States Patent and Trademark Office Patents 1237(5)

D.Bruijn, Jacobus 2004: Tall fescue variety having rhizomes. Official Gazette of the United States Patent and Trademark Office Patents 1278(2)

Hamilton, D.; Batstone, P.; Forsyth, L.; Ghaffari, S.; Mohammed, F.; Boyd, E. 2000: Tall stature, gonadal dysgenesis and lack of Turner syndrome features in a patient with a rearranged X chromosome. Journal of Medical Genetics 37(Suppl 1): S53

Shu, Hong Bing 2002: Tall-1 receptor homologues. Official Gazette of the United States Patent and Trademark Office Patents 1264(1)

Lamb, C.; Vissoneau, S.; Gup, C.; Gomez, G.; Demasters, B.K.; Santoli, D.; Kruse, C.A. 1999: Tall-104 cell killing of human malignant brain tumors by necrotic/apoptotic events and the trafficking of TALL-104 cells through tumor-bearing rat brain. FASEB Journal 13(4 Part 1): A302

Kues, A.B. 2010: Taller - Healthier - more equal? the biological standard of living in Switzerland in the second half of the 20th century. Economics and Human Biology 8(1): 67-79

Blumenthal, D.M.; Jordan, N.R.; Svenson, E.L. 2003: Tallgrass prairie restoration controls weeds. Ecological Society of America Annual Meeting Abstracts 88: 36

Slowik, N. 1999: Tallman State Park, Rockland County, NY, April 11, 1998. Journal of the Torrey Botanical Society 126(1): 90

Ugolini, A.; Vignali, B.; Posso, P. 1999: Talorchestia tricornuta shoemaker from sandy shores of Gabon Compass mechanisms of orientation. Ethology 105(1): 25-36

Sato, K.; Morimoto, K.; Suemaru, S.; Sato, T.; Yamada, N. 1999: Talpha1-tubulin and synapsin I mRNAs expression in an experimental epileptic status model The comparison with long-term potentiation. Epilepsia 40(Suppl 2): 149-150

Gum, E.K.; Hsu, J.Y.; Knudsen, K.F.; Wyant, L.B. 1999: Tamale product. Official Gazette of the United States Patent and Trademark Office Patents 1229(4)

Doorty, K.B.; Wadsworth, J.D.F.; Dunbar, B.; Kini, M.; Yemul, V.L.; Kamat, R.; Gadre, S.V.; Gopalakrishnakone, P.; Jeyaseelan, K.; Strong, P.N. 2001: Tamapin A peptide with apamin-like activity from the venom of the Indian red scorpion, Mesobuthus tamulus. Toxicon 39(2-3): 137-138

Mowery, D.; Wallace, L. 2001: Tamarix response to flooding frequency and depth. Ecological Society of America Annual Meeting Abstracts 86: 163

Takakura, Y.; Oka, N.; Kajiwara, H.; Tsunashima, M.; Usami, S.; Tsukamoto, H.; Ishida, Y.; Yamamoto, T. 2010: Tamavidin, a versatile affinity tag for protein purification and immobilization. Journal of Biotechnology 145(4): 317-322

Steele, M.A. 1999: Tamiasciurus douglasii. Mammalian Species 630: 1-8

Hollingsworth, R.I. 1999: Taming carbohydrate complexity A facile, high-yield route to chiral 2,3-dihydroxybutanoic acids and 4-hydroxytetrahydrofuran-2-ones with very high optical purity from pentose sugars. Abstracts of Papers American Chemical Society 218(1-2): CARB 88

Shackford, S.R.; Connolly, J.F. 2003: Taming of the screw: a case report and literature review of limb-threatening complications after plate osteosynthesis of a clavicular nonunion. Journal of Trauma 55(5): 840

Iskenderian, W.S.; Boal, A.K.; Allen, B.D.; Steinmetz, W.E.; Grubbs, R.H.; O'leary, D.J.; Blackwell, H.E. 2003: Taming the elusive 310-helix Synthesis and conformational analysis of macrocyclic heptapeptides. Abstracts of Papers American Chemical Society 225(1-2): CHED 601

Grewal, A. 2003: Taming the mass of microarray data Systematic approaches to gene expression analysis. Inoue, Tohru , Reprint Author, Pennie, William D Toxicogenomics: 62-69

Raffi, H.S.; Bates, J.M.J.; Kumar, S. 2003: Tamm Horsfall protein-deficient mice are more prone to cystitis but not to pyelonephritis. Journal of the American Society of Nephrology 14(Abstracts Issue): 377A

Bates, J.M.J.; Raffi, H.S.; Kumar, S. 2003: Tamm horsfall protein clumps type1 fimbriated escherichia coli and acts as a host defense factor against urinary tract infection. Journal of the American Society of Nephrology 14(Abstracts Issue): 641A

Bates, J.M.; Raffi, H.S.; Prasadan, K.; Shenoi, J.; Kumar, S. 2002: Tamm-Horsfall Protein gene knockout mice are more prone to urinary tract infection. Journal of the American Society of Nephrology 13(Program and Abstracts Issue): 55A

Shihabi, Z.K.; Hinsdale, M.; Bleyer, A.J. 2004: Tamm-Horsfall protein aggregation by capillary electrophoresis. Clinical Chemistry 50(6, Suppl S, Part 2): A62

Shiozawa, H.; Stein, P.C.; Parsons, C.L.well 1999: Tamm-Horsfall protein cytotoxicity in interstitial cystitis. Journal of Urology 161(4 Suppl): 27

Sokolic, L.; Ljubic, S.; Pavlic Renar, I.; Metelko, Z. 1999: Tamm-Horsfall protein excretion rate value in early detection of diabetic nephropathy. Clinical Chemistry and Laboratory Medicine 37(SPEC Suppl ): S195

Rhodes, Diana, C.J. 2003: Tamm-Horsfall protein inhibits activation of the classical complement pathway. Journal of the American Society of Nephrology 14(Abstracts Issue): 162A-163A

Kokot, F.; Duława, J. 2000: Tamm-Horsfall protein updated. Nephron 85(2): 97-102

Elefsiniotis, I.S.; Pantazis, K.D.; Ilias, A.; Pallis, L.; Mariolis, A.; Glynou, I.; Kada, H.; Moulakakis, A. 2004: Tamoxifen induced hepatotoxicity in breast cancer patients with pre-existing liver steatosis: the role of glucose intolerance. European Journal of Gastroenterology and Hepatology 16(6): 593-598